Copyright © Philip M. Parker, INSEAD. Terms of Use.
| PH ADJUSTED NONIONIC SURFACTANT-CONTAINING ALKALINE CLEANER COMPOSITION FOR CLEANING MICROELECTRONICS SUBSTRATES
PH ADJUSTMENT OF A STRENGTHENING MELT FOR USE IN STRENGTHENING GLASS SUBSTRATES
PH ADJUSTORS AND DRINKS USING THE SAME
PH AND AMINE TEST ELEMENTS
PH AND AMINE TEST ELEMENTS AND APPLICATIONS TO DIAGNOSIS OF VAGINAL INFECTIONS
PH AND AMINE TEST TO DIAGNOSIS OF VAGINAL INFECTIONS
PH AND CONCENTRATION METER
PH AND PCO.SUB.2 SENSING BY LUMINESCENT LIFETIMES AND ENERGY TRANSFER
PH AND TEMPERATURE SENSITIVE TERPOLYMERS FOR ORAL DRUG DELIVERY
PH BUFFERED COMPOSITIONS USEFUL FOR CLEANING RESIDUE FROM SEMICONDUCTOR SUBSTRATES
PH CONTROL METHOD OF REDUCING NITROGEN OXIDES EMISSION
PH CONTROL OF LEACHABLE MERCURY IN FLUORESCENT LAMPS
PH CONTROL POLYMER
PH CONTROL PROCESS AND SYSTEM
PH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS
PH DEPENDENT MEMBRANE DIFFUSION
PH DEPENDENT POLYMER MICELLES
PH DEPENDENT PROCESS FOR RETARDING THE GELATION RATE OF A POLYMER GEL UTILIZED TO REDUCE PERMEABILITY IN OR NEAR A SUBTERRANEAN HYDROCARBON-BEARING FORMATION
PH DETECTION AND MEASUREMENT OF BODY FLUID
PH ELECTRODE
PH ELECTRODE ARRANGEMENT
PH GENES AND THEIR USES
PH GLASS ELECTRODE
PH INDEPENDENT EXTENDED RELEASE PHARMACEUTICAL FORMULATION
PH MEASUREMENT OF BODY FLUID
PH MEASUREMENT UTILIZING A LIGHT SOURCE
PH MEASURING SYSTEM
PH MODIFICATION OF GEOTHERMAL BRINE WITH SULFUR-CONTAINING ACID
PH OPTRODE
PH REDUCING FORMULATION AND DELIVERY SYSTEM FOR A TAMPON
PH SENSITIVE MRI CONTRAST AGENTS
PH SENSITIVE REFERENCE ELECTRODE IN ELECTROLYTIC DESILVERING
PH SENSITIVE THERMOPLASTIC BINDER
PH SENSITIVE, REVERSIBLE GELLING, COPOLYMERIC ERODIBLE DRUG DELIVERY SYSTEM
PH SENSOR
PH SENSOR AND PH MEASUREMENT METHOD EMPLOYING THE SAME
PH SENSOR FOR INDICATING THE PH OF A SAMPLE
PH SENSOR WITH ELECTRICAL NOISE IMMUNITY
PH TEST ELEMENTS
PH TOLERANT HETEROPOLYSACCHARIDE GELS FOR USE IN PROFILE CONTROL
PH-BUFFERED SLURRY AND USE THEREOF FOR POLISHING
PH-CONTROLLED RELEASE OF DETERGENT COMPONENTS
PH-DEPENDENT SUSTAINED RELEASE, DRUG-DELIVERY COMPOSITION
PH-INDICATING MATERIAL AND CAT LITTER CONTAINING SAME
PH-MODIFIED BIOCOMPATIBLE MONOMER AND POLYMER COMPOSITIONS
PH-MODIFIED POLYMER COMPOSITIONS WITH ENHANCED BIODEGRADABILITY
PH-NEUTRAL AQUEOUS SOLUTIONS OF QUINOLONE-CARBOXYLIC ACIDS
PH-SELECTIVE DELIVERY SYSTEM USING CROSSLINKED POLYMERIC RESINS AS VEHICLES
PH-SENSITIVE COATINGS BASED ON CELLULOSE ACETOACETATE
PH-SENSITIVE IMMUNOLIPOSOMES AND METHOD OF GENE DELIVERY TO THE MAMMALIAN CENTRAL NERVOUS SYSTEM
PH-SENSITIVE MICROCAPSULES
PH-SENSITIVE MICROSENSOR AND A METHOD OF MANUFACTURING A PH-SENSITIVE MICROSENSOR
PH-SENSITIVE MODIFIED CELLULOSE ESTER
PH-SENSITIVE POLYMER CONTAINING SULFONAMIDE AND ITS SYNTHESIS METHOD
PH-SENSITIVE, SERUM-STABLE LIPOSOMES
PH-TRIGGERED OSMOTIC BURSTING DELIVERY DEVICES
PH-ZONE-REFINING COUNTERCURRENT CHROMATOGRAPHY
PHA COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF PHA FILMS
PHA E AND PHA C COMPONENTS OF POLY(HYDROXY FATTY ACID) SYNTHASE FROM THIOCAPSA PFENNIGII
PHACO HANDPIECE PROVIDING FINGERTIP CONTROL OF ULTRASONIC ENERGY
PHACO THERMAL CONTROL APPARATUS AND METHOD
PHACO TIP WITH FLUID BYPASS PORT
PHACO-EXTRACTOR FOR FRAGMENTING CATARACTOUS-LENS SITUS OF FRAGMENTATION
PHACO-SHIELD FOR PROTECTING THE POSTERIOR CAPSULE DURING PHACO-EMULSIFICATION
PHACOEMULSIFICATION APPARATUS
PHACOEMULSIFICATION APPARATUS WITH PERSONAL COMPUTER
PHACOEMULSIFICATION CUTTING TIP
PHACOEMULSIFICATION DEVICE AND METHOD FOR USING DUAL LOOP FREQUENCY AND POWER CONTROL
PHACOEMULSIFICATION HANDPIECE
PHACOEMULSIFICATION HANDPIECE, SLEEVE, AND TIP
PHACOEMULSIFICATION INSTRUMENT HAVING A GAP BETWEEN A NEEDLE AND A SLEEVE OF THE INSTRUMENT THAT IS AT LEAST THE SAME SIZE AS AN INSIDE AREA OF AN INFUSION LINE
PHACOEMULSIFICATION METHOD AND APPARATUS
PHACOEMULSIFICATION NEEDLE
PHACOEMULSIFICATION PROBE CIRCUIT WITH PULSE WIDTH MODULATING DRIVE
PHACOEMULSIFICATION PROBE CIRCUIT WITH SWITCH DRIVE
PHACOEMULSIFICATION PROBE DRIVE CIRCUIT
PHACOEMULSIFICATION SLEEVE
PHACOEMULSIFICATION SYSTEM HAVING ULTRASONIC POWER CONTROLLED BY ASPIRATION VACUUM SENSOR
PHACOEMULSIFICATION SYSTEM WITH HANDPIECE SIMULATOR
PHACOEMULSIFICATION TRANSDUCER WITH ROTATABLE HANDLE
PHACOEMULSIFICATION, IRRIGATION AND ASPIRATION METHOD AND APPARATUS
PHACOPHOTOLYSIS METHOD AND APPARATUS
PHAFFIA RHODOZYMA MUTANTS, PROCESS FOR PRODUCING .BETA.-CAROTENE AND USE OF .BETA.-CAROTENE RICH BIOMASS
PHAGE ANTIBODIES
PHAGE BONDED TO A NUCLEAR LOCATION SIGNAL
PHAGE DEFENSE ROTATION STRATEGY
PHAGE DISPLAY FOR DETERGENT ENZYME ACTIVITY
PHAGE WITH NUCLEAR LOCALIZATION SIGNAL
PHAGE-COSMID HYBRID VECTOR, OPEN COS DNA FRAGMENTS, THEIR METHOD OF USE, AND PROCESS OF PRODUCTION
PHAGE-DEPENDENT SUPER-PRODUCTION OF BIOLOGICALLY ACTIVE PROTEIN AND PEPTIDES
PHAGE-DEPENDENT SUPERPRODUCTION OF BIOLOGICALLY ACTIVE PROTEIN AND PEPTIDES
PHAGE-DISPLAY OF IMMUNOGLOBULIN HEAVY CHAIN LIBRARIES
PHAGE-DISPLAY OF IMMUNOGLOBULIN HEAVY CHAIN LIBRARIES FOR IDENTIFICATION OF INHIBITORS OF INTRACELLULAR CONSTITUENTS
PHAGE-RESISTANT STREPTOCOCCUS
PHAGEMID FOR ANTIBODY SCREENING
PHAGEMID LIBRARY FOR ANTIBODY SCREENING
PHAGEMIDS AND PROCESS OF PREPARATION
PHAGEMIDS COEXPRESSING A SURFACE RECEPTOR AND A SURFACE HETEROLOGOUS PROTEIN
PHAGOCYTOSIS ACTIVATOR COMPOSITIONS AND THEIR USE
PHAKIC INTRAOCULAR LENSES
PHAKIC IOL FILM FRAME
PHAKIC OR APHAKIC INTRAOCULAR LENS ASSEMBLY
PHALANGEAL FINGER JOINT PROSTHESIS AND METHOD
PHALANGEAL JOINT PROSTHESIS
PHALANX SPLINT
PHANEROCHAETE CHRYSOSPOIRIUM STRAINS CNCM I-1511, I-1512 AND I-1513 FOR PRODUCING LIGNIN PEROXIDASE AND MANGANESE PEROXIDASE
PHANTOM AND METHOD FOR ACCURACY AND REPEATABILITY TESTING OF POSITIONAL MECHANISMS OF COMPUTER ASSISTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING SYSTEMS
PHANTOM AND METHOD FOR EVALUATING CALCIUM SCORING
PHANTOM ASSEMBLY TO VERIFY ACCURACY OF A CARBON MONOXIDE DIFFUSING CAPACITY MEASURING DEVICE
PHANTOM BUFFER FOR INTERFACING BETWEEN BUSES OF DIFFERING SPEEDS
PHANTOM COLOR LIGHT MIRROR
PHANTOM DATA LINK FOR DIGITAL TRANSMISSION LINES
PHANTOM DUPLEX COPY GROUP APPARATUS FOR A DISK DRIVE ARRAY DATA STORGE SUBSYSTEM
PHANTOM FILES FOR DYNAMIC READ BANDWIDTH MEASUREMENTS OF COMPUTER DISKS
PHANTOM FLOW CONTROL METHOD AND APPARATUS
PHANTOM FLOW CONTROL METHOD AND APPARATUS WITH IMPROVED STABILITY
PHANTOM FOR A DENTAL PANORAMIC X-RAY APPARATUS
PHANTOM FOR MEASURING SLICE THICKNESSES, SLICE SENSITIVITY PROFILES AND THE AXIAL MODULATION TRANSFER FUNCTION IN AN X-RAY COMPUTED TOMOGRAPHY APPARATUS
PHANTOM FOR OPTICAL AND MAGNETIC RESONANCE IMAGING QUALITY CONTROL
PHANTOM FOR SIMULATING AN X-RAY EXAM PATIENT
PHANTOM FOR SIMULATING THE ELECTRIC LOADING IN A MAGNETIC RESONANCE APPARATUS
PHANTOM LEVEL EDGE ENHANCED ERROR DIFFUSION
PHANTOM MOBILE IDENTIFICATION NUMBER METHOD AND APPARATUS
PHANTOM MOBILE-IDENTIFICATION NUMBER METHOD AND APPARATUS
PHANTOM RESOURCE MEMORY ADDRESS MAPPING SYSTEM
PHANTON-POWERED ACTIVE DIRECT BOX
PHARAMACEUTICAL FORMULATION
PHARAMCEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF TOURETTE'S SYNDROME
PHARMACCEUTICAL/COSMETIC COMPOSITIONS COMPRISING SYNERGISTIC ANTIMICROBIAL ADMIXTURE
PHARMACEUTIC FORMULATION FOR THE TREATMENT OF ALCOHOLISM
PHARMACEUTICAL ACCEPTABLE COMPOSITIONS CONTAINING AN ALCOHOL AND A HYDROPHOBIC DRUG
PHARMACEUTICAL ACTIVE CONJUGATES
PHARMACEUTICAL ADMINISTRATION OF ADENOSINE AGONISTS
PHARMACEUTICAL ADMINISTRATION OF ECOTIN HOMOLOGS
PHARMACEUTICAL AEROSOL COMPOSITION AND APPLICATION THEREOF FOR TREATMENT AND PROPHYLAXIS OF VIRAL DISEASES
PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134A
PHARMACEUTICAL AEROSOL CONTAINING AT LEAST ONE SUGAR
PHARMACEUTICAL AEROSOL FORMULATION COMPRISING A MEDICAMENT, A PROPELLANT AND A FLUORINATED SURFACTANT
PHARMACEUTICAL AEROSOL FORMULATION CONTAINING A PARTICULATE MEDICAMENT, A PROPELLANT AND SUBSTANTIALLY FREE OF A SURFACTANT
PHARMACEUTICAL AGENT CONTAINING RHO KINASE INHIBITOR
PHARMACEUTICAL AGENT FOR TREATMENT OF WITHDRAWAL SYMPTOMS
PHARMACEUTICAL AGENTS
PHARMACEUTICAL AGENTS CONTAINING ACYCLOVIR, FUSARIC ACID AND DERIVATIVES THEREOF
PHARMACEUTICAL AGENTS CONTAINING DIPHOSPHONIC ACIDS AND SALTS THEREOF
PHARMACEUTICAL AGENTS CONTAINING METHOTREXATE DERIVATIVE
PHARMACEUTICAL AGENTS FOR PREVENTING THE DEVELOPMENT OF TOLERANCE DURING THE TREATMENT WITH BENZODIAZEPINE-RECEPTOR-BINDING ACTIVE INGREDIENTS
PHARMACEUTICAL AGENTS FOR THE TREATMENT OF DISORDERS CAUSED BY HELICOBACTER PYLORI OR OTHER SPIRAL UREASE-POSITIVE GRAM-NEGATIVE BACTERIA
PHARMACEUTICAL AGENTS FOR THE TREATMENT OF EMESIS
PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON'S DISEASE, ADHD AND MICROADENOMAS
PHARMACEUTICAL AGENTS FOR TREATMENT OF EMESIS
PHARMACEUTICAL AGENTS FOR TREATMENT OF URINARY INCONTINENCE
PHARMACEUTICAL AGENTS THAT CONTAIN PERFLUOROALKYL-CONTAINING METAL COMPLEXES
PHARMACEUTICAL AGENTS THAT IMPEDE THE INITIATION AND PROGRESSION OF PRIMARY AND SECONDARY DMS DISRUPTIONS
PHARMACEUTICAL AGENTS USEFUL AS LEUKOTRIENE ANTAGONISTS
PHARMACEUTICAL ALPHA-KETO CARBOXYLIC ACID COMPOSITIONS METHOD OF MAKING AND USE THEREOF
PHARMACEUTICAL ALPHA-KETO CARBOXYLIC ACID COMPOSITIONS, METHOD OF MAKING AND USE THEREOF
PHARMACEUTICAL AMINOPHOSPHONIC ACID DERIVATIVES
PHARMACEUTICAL AMIODARONE COMPOSITION FOR PARENTERAL DELIVERY
PHARMACEUTICAL AMPUL
PHARMACEUTICAL AND ALIMENTARY COMPOSITIONS CONTAINING BACTERIA OF GENUS ACETOBACTER
PHARMACEUTICAL AND COSMETIC COMPOSITIONS AND THEIR PRODUCTION
PHARMACEUTICAL AND COSMETIC DEPIGMENTATION COMPOSITIONS WITH A CAFFEIC ACID BASE
PHARMACEUTICAL AND COSMETIC FORMULATIONS WITH ANTIMICROBIAL ACTIVITY
PHARMACEUTICAL AND DERMOCOSMETIC COMPOSITIONS CONTAINING EQUINE COLOSTRUM
PHARMACEUTICAL AND DIAGNOSTIC USE OF SERUM AMYLOID P COMPONENT
PHARMACEUTICAL AND DIET FORMULATIONS FOR THE PROPHYLAXIS AND TREATMENT OF GASTROINTESTINAL DISORDERS
PHARMACEUTICAL AND ITS USE FOR THE TREATMENT OF STATES OF AGITATION AND NERVOUS DYSFUNCTIONS
PHARMACEUTICAL AND OTHER DOSAGE FORMS
PHARMACEUTICAL AND VETERINARY COMPOSITIONS OF MUPIROCIN AND METHODS FOR THEIR PREPARATION
PHARMACEUTICAL AND/OR DIETETIC COMPOSITIONS WITH ANTIOXIDANT ACTIVITY CONTAINING CARNOSINE OR DERIVATIVES AND BRANCHED AMINO ACIDS
PHARMACEUTICAL ANGIOSTATIC DIPEPTIDE COMPOSITIONS AND METHOD OF USE THEREOF
PHARMACEUTICAL ANGIOSTATIC DIPEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF
PHARMACEUTICAL ANTACID
PHARMACEUTICAL ANTIVIRAL COMPOSITION COMPRISING GLYCYRRHIZIC ACID AND AT LEAST ONE PROTEIN ENDOWED WITH ANTIVIRAL ACTIVITY
PHARMACEUTICAL APPLICATIONS FOR METHANEDIPHOSPHONATE DERIVATIVE
PHARMACEUTICAL AQUEOUS FORMULATIONS CONTAINING A SPARINGLY SOLUBLE PHARMACEUTICAL ACTIVE COMPOUND WITH A SOLUBILIZING POLYMERIC AGENT
PHARMACEUTICAL AQUEOUS SOLUTION OF 4-[2-(BENZENE-SULPHONYLAMINO)-ETHYL]-PHENOXYACETIC ACID
PHARMACEUTICAL BACTERIOCIN COMPOSITIONS AND METHODS FOR USING THE SAME
PHARMACEUTICAL BASE AND THE USE OF THE SAME
PHARMACEUTICAL BONE GROWTH-PROMOTING COMPOSITION AND PROCESS
PHARMACEUTICAL BOTTLE OF TWO SEPARATE SUBSTANCES WITH MIXING DEVICE, DOSED APPLICATION AND ASSEMBLY PROCESS THEREOF
PHARMACEUTICAL CABINET LOCKING ARRANGEMENT
PHARMACEUTICAL CAPSULE AND METHOD OF MAKING
PHARMACEUTICAL CAPSULE COMPOSITIONS CONTAINING LORATADINE AND PSUEDOEPHEDRINE
PHARMACEUTICAL CAPSULES COMPRISING A CYCLOSPORIN
PHARMACEUTICAL CARRIER
PHARMACEUTICAL CARRIER FORMULATION
PHARMACEUTICAL CARRIER SYSTEM CONTAINING DEFINED LIPIDS
PHARMACEUTICAL CHEWING GUM CONTAINING ACETYLSALICYLIC ACID
PHARMACEUTICAL COATING SUGARS
PHARMACEUTICAL COMBINATION
PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A INOS INHIBITOR
PHARMACEUTICAL COMBINATION FOR THE PROPHYLAXIS AND THERAPY OF MALARIA
PHARMACEUTICAL COMBINATION OF ANTIVIRAL AGENTS
PHARMACEUTICAL COMBINATION PREPARATION COMPRISING KETOPROFEN
PHARMACEUTICAL COMBINATION PREPARATION FOR HORMONAL CONTRACEPTION
PHARMACEUTICAL COMBINATION PREPARATION OF AN INHIBITOR OF THE SODIUM/HYDROGEN EXCHANGER AND A MEDICAMENT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING CEPHALOSPORIN AND XANTHINE DERIVATIVES AND THEIR USE
PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING ERYTHROPOIETIN AND IRON PREPARATIONS
PHARMACEUTICAL COMBINATION PREPARATIONS CONTAINING ERYTHROPOIETIN AND MODIFIED HAEMOGLOBINS
PHARMACEUTICAL COMBINATIONS BASED ON DALFOPRISTINE AND QUINUPRISTINE, AND ON CEFEPIME
PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF STROKE AND TRAUMATIC BRAIN INJURY
PHARMACEUTICAL COMBINATIONS FOR TREATING OBESITY AND FOOD CRAVING
PHARMACEUTICAL COMBINED PREPARATION, KIT AND METHOD FOR HORMONAL CONTRACEPTION
PHARMACEUTICAL COMPLEX
PHARMACEUTICAL COMPONENT-MIXING DELIVERY ASSEMBLY
PHARMACEUTICAL COMPOSITION
PHARMACEUTICAL COMPOSITION ACTIVE IN REDUCING PRODUCTION OF MCP-1 PROTEIN
PHARMACEUTICAL COMPOSITION AGAINST AIDS
PHARMACEUTICAL COMPOSITION AGAINST TYPE I ALLERGY AND THE PREPARATION THEREOF
PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATING NEURODEGENERATIVE DISEASES USING A COMBINATION OF A KAINATE EXCITATORY AMINO ACID ANTAGONIST AND AN URICOSURIC AGENT
PHARMACEUTICAL COMPOSITION AND DIETARY SUPPLEMENT CONTAINING DOCOSAREXAENOIC ACID OBTAINED FROM DINOFLAGELLATES
PHARMACEUTICAL COMPOSITION AND ITS MUCOSAL USE
PHARMACEUTICAL COMPOSITION AND METHOD FOR ANGIOGENESIS INHIBITION
PHARMACEUTICAL COMPOSITION AND METHOD FOR HYPERMETABOLIC WEIGHT LOSS
PHARMACEUTICAL COMPOSITION AND METHOD FOR IMMUNOENHANCEMENT THERAPY
PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITING HAIR GROWTH BY ADMINISTRATION OF ACTIVIN OR ACTIVIN AGONISTS
PHARMACEUTICAL COMPOSITION AND METHOD FOR MODULATING THE IMMUNE REACTION
PHARMACEUTICAL COMPOSITION AND METHOD FOR THE CONTROL OF HYPERTENSION
PHARMACEUTICAL COMPOSITION AND METHOD FOR THE SUPPRESSION OF FACTOR VIII INHIBITOR PRODUCTION
PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF NEOPLASTIC CELLS
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING CARDIOVASCULAR DISEASES USING SUBSTITUTED ANILIDES AND SULFONAMIDES
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING PREMATURE LABOR
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING VULVITIS OR VULVOVAGINITIS
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF DYSPEPSIA
PHARMACEUTICAL COMPOSITION AND METHOD OF INTRANASAL ADMINISTRATION
PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT UTILIZING THE COMPOSITION
PHARMACEUTICAL COMPOSITION AND METHOD OF USE
PHARMACEUTICAL COMPOSITION AND METHOD OF USING THE SAME
PHARMACEUTICAL COMPOSITION AND METHODS FOR USING IT
PHARMACEUTICAL COMPOSITION AND OF USING THE SAME
PHARMACEUTICAL COMPOSITION AND PREPARATION FOR THE TREATMENT OF SNORING AND THE USE THEREOF
PHARMACEUTICAL COMPOSITION AND PROCESS FOR ITS PREPARATION
PHARMACEUTICAL COMPOSITION AND PROCESS FOR THE PREPARATION THEREOF
PHARMACEUTICAL COMPOSITION AND PROCESS FOR THE PRODUCTION THEREOF
PHARMACEUTICAL COMPOSITION AND THE METHOD FOR TREATING DRUG ADDICTS' WITHDRAWAL SYNDROMES AND DETOXIFYING ADDICTS BY THE SAME
PHARMACEUTICAL COMPOSITION AND THE PROCESS FOR ITS PREPARATION
PHARMACEUTICAL COMPOSITION AND USE
PHARMACEUTICAL COMPOSITION AND USES THEREFOR
PHARMACEUTICAL COMPOSITION BASED ON COCAETHYLENE AND USE THEREOF FOR TREATING PSYCHOACTIVE SUBSTANCE DEPENDENCE
PHARMACEUTICAL COMPOSITION BASED ON ESTROGEN AND PROGESTERONE
PHARMACEUTICAL COMPOSITION BASED ON POLYAROMATIC COMPOUNDS
PHARMACEUTICAL COMPOSITION BASED ON TAXOIDS
PHARMACEUTICAL COMPOSITION BASED ON VALPROIC ACID AND A PROCESS FOR PREPARING IT
PHARMACEUTICAL COMPOSITION CAPABLE OF REGULATING THE EXPRESSION OF ADHESION MOLECULES
PHARMACEUTICAL COMPOSITION COMPRISED OF CISPLATIN, AND PROCESSES FOR MAKING AND USING SAME
PHARMACEUTICAL COMPOSITION COMPRISING 2,4-DIAMINO-6-BENZYLOXY-S-TRIAZINE AND INACTIVATION OF O6-ALKYLGUANINE-DNA-ALKYLTRANSFERASE
PHARMACEUTICAL COMPOSITION COMPRISING 5,6-DIHYDRODIBENZO[A,G] QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF | PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METFORMIN AND FIBRATE, AND ITS USE FOR THE PREPARATION OF MEDICINES INTENDED TO REDUCE HYPERGLYCAEMIA
PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-XA ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
PHARMACEUTICAL COMPOSITION COMPRISING A GLUCOSIDASE AND/OR AMYLASE INHIBITOR, AND A LIPASE INHIBITOR
PHARMACEUTICAL COMPOSITION COMPRISING A MEDICAMENT AND 3-OXYGERMYLPROPIONIC ACID
PHARMACEUTICAL COMPOSITION COMPRISING A SPIRO OXATHIOLON/QUINUCLIDINE AND METHOD OF TREATING SENILE DEMENTIA
PHARMACEUTICAL COMPOSITION COMPRISING A SUSPENSION FOR THE ACTIVE INGREDIENT
PHARMACEUTICAL COMPOSITION COMPRISING ALBUMIN AS AN ACTIVE INGREDIENT
PHARMACEUTICAL COMPOSITION COMPRISING AN AQUEOUS EXTRACT OF A MIXTURE OF ANEMARRHENA RHIZOMA AND PHELLODEDRON BARK FOR ANALGESIC AND ANTI-INFLAMMATION
PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE AMINOPEPTIDASE A INHIBITOR
PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST TYROSINE AND AN IRON COMPOUND FOR TREATING PARKINSON'S DISEASE OR DEPRESSION
PHARMACEUTICAL COMPOSITION COMPRISING BPI PROTEINS
PHARMACEUTICAL COMPOSITION COMPRISING BUPROPION HYDROCHLORIDE AND FUMARIC ACID
PHARMACEUTICAL COMPOSITION COMPRISING CALCIUM POLYCARBOPHIL
PHARMACEUTICAL COMPOSITION COMPRISING CARNITINE OR ALKANOYL L-CARNITINE, FOR THE PREVENTION AND TREATMENT OF DISEASES BROUGHT ABOUT BY LIPID METABOLISM DISORDERS
PHARMACEUTICAL COMPOSITION COMPRISING COENZYME Q10
PHARMACEUTICAL COMPOSITION COMPRISING CRYPTOSPORIDIUM PARVUM OOCYSTS ANTIGEN AND WHOLE CELL CANDIDA SPECIES ANTIGEN
PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORIN
PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORIN IN ASSOCIATION WITH A CARRIER IN A SELF-EMULSIFYING DRUG DELIVERY SYSTEM
PHARMACEUTICAL COMPOSITION COMPRISING CYCLOSPORIN SOLID-STATE MICROEMULSION
PHARMACEUTICAL COMPOSITION COMPRISING DAUNORUBICIN POTENTIATED WITH 2,4,5-TRI (4-METHOXYPHENYL)-4,5-DIHYDROIMIDAZOLE
PHARMACEUTICAL COMPOSITION COMPRISING DICLOFENAC AND CYCLODEXTRIN
PHARMACEUTICAL COMPOSITION COMPRISING ENTACAPONE, LEVODOPA, AND CARBIDOPA
PHARMACEUTICAL COMPOSITION COMPRISING EXTRACT FROM PLANT CRYPTOLEPIS BUCHANANI FOR TREATING IMMUNODEFICIENCY
PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VIII AND NEUTRAL LIPOSOMES
PHARMACEUTICAL COMPOSITION COMPRISING FENOFIBRATE
PHARMACEUTICAL COMPOSITION COMPRISING FLUPIRTINE AND ITS USE TO COMBAT MUSCULAR TENSION
PHARMACEUTICAL COMPOSITION COMPRISING FLUPIRTINE AND ITS USE TO COMBAT PARKINSON DISORDERS
PHARMACEUTICAL COMPOSITION COMPRISING HIV PROTEASE INHIBITING COMPOUNDS
PHARMACEUTICAL COMPOSITION COMPRISING L-CARNITINE OR AN ALKANOYL L-CARNITINE IN COMBINATION WITH A POLYUNSATURATED FATTY ACID OF THE OMEGA-3 SERIES FOR THE PREVENTION AND THE TREATMENT OF LIPID METABOLISM DISORDERS
PHARMACEUTICAL COMPOSITION COMPRISING L-CARNITINE OR DERIVATIVE THEREOF AND TRIHYDROXY OR TETRAHYDROXYSTILBENE
PHARMACEUTICAL COMPOSITION COMPRISING MIRTAZAPINE AND ONE OR MORE SELECTIVE SEROTONIN REUPTAKE INHIBITORS
PHARMACEUTICAL COMPOSITION COMPRISING RIBAVIRIN AND GROWTH FACTORS AND METHODS OF USE
PHARMACEUTICAL COMPOSITION COMPRISING ROSA ROXBURGHII, ARTEMISIAE ARGYI FOLIUM AND BRASSICA OLERACEA VAR. CAPITATA L. USED TO REDUCE THE SYMPTOMS OF DIARRHEA
PHARMACEUTICAL COMPOSITION COMPRISING SERUM AMYLOID P COMPONENT FOR PROPHYLACTIC OR THERAPEUTIC TREATMENT OF VIRUS INFECTIONS AND A KIT FOR DETECTING BINDING OF COMPOSITIONS TO VIRUS COMPONENTS
PHARMACEUTICAL COMPOSITION COMPRISING STARCH, A COMPOUND COMPRISING BORON, A COMPOUND COMPRISING ZINC, AND WATER, AND A METHOD OF USING SAME TO ENCOURAGE HAIR GROWTH
PHARMACEUTICAL COMPOSITION COMPRISING TICLOPIDINE AND GINKGO BILOBA EXTRACT
PHARMACEUTICAL COMPOSITION COMPRISING ZIDOVUDINE AND INOSIPLEX OR COMPONENTS THEREOF FOR THE TREATMENT OF AIDS-RELATED SYNDROMES
PHARMACEUTICAL COMPOSITION CONTAINING .GAMMA.-HYDROXYBUTYRIC ACID OR ITS LACTONE IN THE TREATMENT OF DRUG DEPENDENCE AND NUTRITIONAL DISORDERS
PHARMACEUTICAL COMPOSITION CONTAINING 2-AMINO-6-CHLOROPURINE-9-.BETA.-D-2',3'-DIDEOXYRIBOFURANOXSIDE
PHARMACEUTICAL COMPOSITION CONTAINING 2-O-.ALPHA.-D-GLUCOPYRANOSYL-L-ASCORBIC ACID
PHARMACEUTICAL COMPOSITION CONTAINING 4-OXO-BUTYNIC ACIDS
PHARMACEUTICAL COMPOSITION CONTAINING 5-MORPHOLINOMETHYL-3-(4-CHLOROBENZYLIDENEAMINE)-2-OXAZOLIDINONE AND ITS USE FOR THE TREATMENT OF CNS DISORDERS
PHARMACEUTICAL COMPOSITION CONTAINING A 5-HT RECEPTOR ANTAGONIST AND AN H.SUP.+ K.SUP.+ ATPASE INHIBITOR AND A METHOD OF TREATING GASTROINTESTINGAL DISORDERS THEREWITH
PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF A STATIN AND ASPIRIN AND METHOD
PHARMACEUTICAL COMPOSITION CONTAINING A CYSTEINE PROTEASE INHIBITOR FOR PROPHYLAXIS AND THERAPY OF BRAIN TISSUE IMPAIRMENT
PHARMACEUTICAL COMPOSITION CONTAINING A DEFINED LIPID SYSTEM
PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/.BETA.-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE
PHARMACEUTICAL COMPOSITION CONTAINING A FUSIBLE CARRIER AND METHOD FOR PRODUCING THE SAME
PHARMACEUTICAL COMPOSITION CONTAINING A HYDROPHILIC ACTIVE COMPOUND, TREATED WITH AN ORGANIC ACID AND ENCAPSULATED IN A LIPOSOME
PHARMACEUTICAL COMPOSITION CONTAINING A LOCAL ANESTHETIC AND/OR CENTRALLY ACTING ANALGESIC ENCAPSULATED IN LIPOSOMES
PHARMACEUTICAL COMPOSITION CONTAINING A LOW DETERGENT EFFECT BILE SALT AND AN ACTIVE COMPOUND THAT UNDERGOES BILIARY EXCRETION AND/OR ENTEROHEPATIC RECYCLING
PHARMACEUTICAL COMPOSITION CONTAINING A MIXED EXTRACT OF PHELLODENDRON AMURENSE RUPRECHT CORTEX AND PATRINIA SCABIOSAEFOLIA FISCH. FOR TREATMENT OF HEPATITIS C
PHARMACEUTICAL COMPOSITION CONTAINING A NEUTRALIZED VIRUS AND USE THEREOF
PHARMACEUTICAL COMPOSITION CONTAINING ACID ADDITION SALT OF BASIC DRUG
PHARMACEUTICAL COMPOSITION CONTAINING AN ACID-LABILE OMEPRAZOLE AND PROCESS FOR ITS PREPARATION
PHARMACEUTICAL COMPOSITION CONTAINING AN INHIBITOR OF IMMUNOGLOBULIN-RECEPTOR INTERACTION
PHARMACEUTICAL COMPOSITION CONTAINING AN ISOLATED PROTEASE PROENZYME, AMYLASE, AND APROTININ
PHARMACEUTICAL COMPOSITION CONTAINING BICYCLIC TYPE COMPOUNDS
PHARMACEUTICAL COMPOSITION CONTAINING BILE ACID SEQUESTRANT ENCLOSED IN A SIZE-EXCLUSION MEMBRANE
PHARMACEUTICAL COMPOSITION CONTAINING BIOLOGICALLY ACTIVE PEPTIDE OR PROTEIN
PHARMACEUTICAL COMPOSITION CONTAINING BISMUTH-POLYACRYLIC ACID COMPOUNDS
PHARMACEUTICAL COMPOSITION CONTAINING BOTULINUM B COMPLEX
PHARMACEUTICAL COMPOSITION CONTAINING BROMOCRYPTINE AND USE OF SAME FOR ACQUIRED IMMUNODEFICIENCY STATES
PHARMACEUTICAL COMPOSITION CONTAINING BUPROPION HYDROCHLORIDE AND A STABILIZER
PHARMACEUTICAL COMPOSITION CONTAINING BUPROPION HYDROCHLORIDE AND AN INORGANIC ACID STABILIZER
PHARMACEUTICAL COMPOSITION CONTAINING CARBACHOL AND OTHER CHOLINERGIC SUBSTANCES
PHARMACEUTICAL COMPOSITION CONTAINING CHITOSAN
PHARMACEUTICAL COMPOSITION CONTAINING COW URINE DISTILLATE AND AN ANTIBIOTIC
PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORIN A
PHARMACEUTICAL COMPOSITION CONTAINING DECURSIN
PHARMACEUTICAL COMPOSITION CONTAINING DEOXYPEGANINE FOR THE TREATMENT OF NICOTINE DEPENDENCE
PHARMACEUTICAL COMPOSITION CONTAINING DESOXYPEGANINE FOR THE TREATMENT OF ALCOHOLISM
PHARMACEUTICAL COMPOSITION CONTAINING DESOXYPEGANINE FOR THE TREATMENT OF DRUG DEPENDENCE
PHARMACEUTICAL COMPOSITION CONTAINING DIPHOSPHONIC ACID OR SALT THEREOF
PHARMACEUTICAL COMPOSITION CONTAINING ESTERS OF .OMEGA.-3 POLYUNSATURATED ACIDS AND THEIR USE IN THE TOPICAL TREATMENT OF MORBID AFFECTIONS
PHARMACEUTICAL COMPOSITION CONTAINING EVODIAMINE COMPOUND AND METHOD FOR IMPROVING LIPID METABOLISM OR ANTIOBESITY
PHARMACEUTICAL COMPOSITION CONTAINING EZRIN MUTATED ON TYROSINE 353
PHARMACEUTICAL COMPOSITION CONTAINING FENOFIBRATE
PHARMACEUTICAL COMPOSITION CONTAINING HEPARIN, HEPARIN FRAGMENTS OR THEIR DERIVATIVES IN COMBINATION WITH GLYCEROL ESTERS
PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN AND A PROSTAGLANDIN
PHARMACEUTICAL COMPOSITION CONTAINING IFN-.GAMMA. INDUCING POLYPEPTIDE OR FACTOR FOR TREATING AND/OR PREVENTING IFN-.GAMMA. SUSCEPTIVE DISEASES
PHARMACEUTICAL COMPOSITION CONTAINING LAMOTRIGINE
PHARMACEUTICAL COMPOSITION CONTAINING LIPOPHILIC DRUGS
PHARMACEUTICAL COMPOSITION CONTAINING MOSAPRIDE AND PANCREATIN
PHARMACEUTICAL COMPOSITION CONTAINING NITRIC OXIDE
PHARMACEUTICAL COMPOSITION CONTAINING OSTEOGENESIS-PROMOTING SUBSTANCE
PHARMACEUTICAL COMPOSITION CONTAINING PECTIN AND A PHOSPHOLIPID USED AS AN ANTIDIARRHEAL AND ANTIULCER AGENT
PHARMACEUTICAL COMPOSITION CONTAINING PROTON PUMP INHIBITORS
PHARMACEUTICAL COMPOSITION CONTAINING PSYLLIUM FIBER AND A LIPASE INHIBITOR
PHARMACEUTICAL COMPOSITION CONTAINING QUINOLINE AND QUINAZOLINE DERIVATIVES AND NOVEL COMPOUNDS THEREFOR
PHARMACEUTICAL COMPOSITION CONTAINING QUINOLINE OR QUINAZOLINE DERIVATIVES
PHARMACEUTICAL COMPOSITION CONTAINING QUINOLINE OR QUINAZOLINE DERIVATIVES AND DERIVATIVES THEREFOR
PHARMACEUTICAL COMPOSITION CONTAINING R-.ALPHA.-LIPOIC ACID OR S-.ALPHA.-LIPOIC ACID AS ACTIVE INGREDIENT
PHARMACEUTICAL COMPOSITION CONTAINING RHEIN OR DIACERHEIN WITH IMPROVED BIOAVAILABILITY
PHARMACEUTICAL COMPOSITION CONTAINING SELECTED LANTHANUM CARBONATE HYDRATES
PHARMACEUTICAL COMPOSITION CONTAINING SIALIC ACID DERIVATIVES
PHARMACEUTICAL COMPOSITION CONTAINING SLIGHTLY WATER-SOLUBLE DRUG
PHARMACEUTICAL COMPOSITION CONTAINING SUCRALFATE
PHARMACEUTICAL COMPOSITION CONTAINING TETRAHYDROCANNABINOL AND A TRANSDERMAL/TRANSCUTANEOUS DELIVERY METHOD THEREOF
PHARMACEUTICAL COMPOSITION CONTAINING THE ACE INHIBITOR RAMIPRIL AND A DIHYDROPYRIDINE COMPOUND
PHARMACEUTICAL COMPOSITION CONTAINING TIAGABINE HYDROCHLORIDE AND THE PROCESS FOR ITS PREPARATION
PHARMACEUTICAL COMPOSITION CONTAINING TWO ACTIVE INGREDIENTS FOR SMOKING CESSATION
PHARMACEUTICAL COMPOSITION CONTAINING USCHARIDIN OR ITS ANALOGUES
PHARMACEUTICAL COMPOSITION CONTAINING ZAFIRLUKAST
PHARMACEUTICAL COMPOSITION ENDOWED WITH AN ANTIALCOHOLIC AND NOOTROPIC EFFECT
PHARMACEUTICAL COMPOSITION FOR ACIDIC LIPOPHILIC COMPOUNDS IN A FORM OF A SELF-EMULSIFYING FORMULATION
PHARMACEUTICAL COMPOSITION FOR AND A METHOD OF USING A COMBINATION OF AN URICOSURIC AGENT AND AN EAA ANTAGONIST
PHARMACEUTICAL COMPOSITION FOR AND METHOD OF TREATING LEUKEMIA
PHARMACEUTICAL COMPOSITION FOR ANGIOTENSIN II-MEDIATED DISEASES
PHARMACEUTICAL COMPOSITION FOR ANTAGONIZING CCR5 COMPRISING ANILIDE DERIVATIVE
PHARMACEUTICAL COMPOSITION FOR COMBINATION OF PIPERIDINOALKANOL-DECONGESTANT
PHARMACEUTICAL COMPOSITION FOR CYCLOSPORINES
PHARMACEUTICAL COMPOSITION FOR IMMUNOENHANCEMENT THERAPY
PHARMACEUTICAL COMPOSITION FOR IMMUNOMODULATING AND ADJUVANT TREATMENT
PHARMACEUTICAL COMPOSITION FOR INCREASING BLADDER CAPACITY
PHARMACEUTICAL COMPOSITION FOR INHALATION CONTAINING CR 2039 (ANDOLAST)
PHARMACEUTICAL COMPOSITION FOR INHIBITING GROWTH OF CANCERS
PHARMACEUTICAL COMPOSITION FOR INHIBITING HIV PROTEASE
PHARMACEUTICAL COMPOSITION FOR INHIBITING INFECTION WITH VIRUS CAUSATIVE OF ACQUIRED HUMAN IMMUNODEFICIENCY SYNDROME
PHARMACEUTICAL COMPOSITION FOR INHIBITING PLATELET AGGREGATION
PHARMACEUTICAL COMPOSITION FOR INHIBITING THE GROWTH OF CANCERS
PHARMACEUTICAL COMPOSITION FOR INHIBITING THE GROWTH OF CANCERS AND VIRUSES IN MAMMALS
PHARMACEUTICAL COMPOSITION FOR INHIBITING THE GROWTH OF VIRUSES AND CANCERS
PHARMACEUTICAL COMPOSITION FOR INHIBITING THE GROWTH OF VIRUSES AND CANCERS COMPRISING THIABENDAZOLE
PHARMACEUTICAL COMPOSITION FOR INHIBITING THE INFECTION WITH AIDS VIRUS
PHARMACEUTICAL COMPOSITION FOR INJECTION BASED ON PARACETAMOL
PHARMACEUTICAL COMPOSITION FOR MODULATING IMMUNITY
PHARMACEUTICAL COMPOSITION FOR MUSCULAR ANABOLISM
PHARMACEUTICAL COMPOSITION FOR NEUROTROPHIC ACTION
PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE
PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE COMPRISING A NONSTEROIDAL ANTI-INFLAMMATORY AND A DECONGESTANT DRUG
PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF A MIXTURE OF CHELATING AGENTS
PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF CHELATING AGENTS
PHARMACEUTICAL COMPOSITION FOR ORAL DELIVERY
PHARMACEUTICAL COMPOSITION FOR ORAL USE
PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION CONTAINING AN INDOLE-CARBOXYLIC ACID
PHARMACEUTICAL COMPOSITION FOR PERITONEAL DIALYSIS
PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALKANOL COMPOUNDS
PHARMACEUTICAL COMPOSITION FOR POTASSIUM SUPPLEMENTATION
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ALLERGIC DISEASES AND A METHOD FOR PREPARATION THEREOF
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ERECTILE IMPOTENCE USING PURIFIED SUMSOO EXTRACT
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RETINAL DISEASES
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING THROMBOSIS
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR CURING DIGESTIVE DISORDERS
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MOTION SICKNESS SYNDROME
PHARMACEUTICAL COMPOSITION FOR PROMOTING THE PROLIFERATION OF HUMAN CORNEAL ENDOTHELIUM AND A METHOD FOR USING THEREOF
PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND THERAPY OF DISEASES ASSOCIATED WITH OCULAR FUNDUS TISSUE CYTOGRAPHY
PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF PREMATURE EJACULATION
PHARMACEUTICAL COMPOSITION FOR PROTECTING THE HEART COMPRISING A HETEROCYCLIC ETHYLENEDIAMINE DERIVATIVE AND METHODS FOR THE USE THEREOF
PHARMACEUTICAL COMPOSITION FOR RAPID SUSPENSION IN AQUEOUS MEDIA
PHARMACEUTICAL COMPOSITION FOR RAPID SUSPENSION IN WATER
PHARMACEUTICAL COMPOSITION FOR RAPID THROMBOLYTIC THERAPY
PHARMACEUTICAL COMPOSITION FOR RECTAL ADMINISTRATION OF ACTIVE PRINCIPLES EXHIBITING A PREVALENTLY TOPICAL MEDICATION ACTION AT THE COLON LEVEL
PHARMACEUTICAL COMPOSITION FOR SKIN DISEASES
PHARMACEUTICAL COMPOSITION FOR THE CONTROL AND TREATMENT OF ANORECTAL AND COLONIC DISEASES
PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF MOGUISTEINE IN A LIQUID SUSPENSION
PHARMACEUTICAL COMPOSITION FOR THE INTRANASAL ADMINISTRATION OF HYDROXOCOBALAMIN
PHARMACEUTICAL COMPOSITION FOR THE METHOD OF TREATING LEUKEMIA
PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF A STABLE POWDER CONTAINING AN ASSOCIATION OF ACETYLSALICYLIC ACID AND METOCLOPRAMIDE AS THE ACTIVE INGREDIENTS
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF SCAR TISSUE
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OF SEXUALLY TRANSMITTED DISEASES
PHARMACEUTICAL COMPOSITION FOR THE PROGRAMMED RELEASE OF DEXFENFLURAMINE
PHARMACEUTICAL COMPOSITION FOR THE SYSTEMIC TRANSDERMAL ADMINISTRATION HAVING THE ACTIVE SUBSTANCE MORPHINE-6-GLUCURONIDE
PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF CEREBRAL THROMBOSIS
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A MALIGNANT TUMOR
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE DISORDERS
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTOIMMUNE DISEASES
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF BLOOD COAGULATION DISEASES, METHODS FOR THE PRODUCTION THEREOF AND ITS USE
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COGNITIVE CEREBROVASCULAR DISEASE
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF FUNCTIONAL DYSPEPSIA AND/OR IRRITABLE BOWEL SYNDROME AND NEW USE OF SUBSTANCES THEREIN
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HIGH BLOOD PRESSURE
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LEUKEMIA CONTAINING 9-CIS-RETINOIC ACID-.ALPHA.-TOCOPHEROL ESTER
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MALIGNANT NEOPLASMS AND IMMUNOSUPPRESSIVE DEFICIENCIES AND ITS METHOD OF PRODUCTION
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SO-CALLED RESTLESS LEGS
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF THE HUMAN EYE
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF A MALIGNANT TUMOR
PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION CONTAINING DITHRANOL AND PREPARATION PROCESS
PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION TO THE EYE FOR TREATING INCREASED INTRAOCULAR PRESSURE
PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATIONS
PHARMACEUTICAL COMPOSITION FOR TOPICAL OPHTHALMIC USE HAVING IMPROVED LOCAL TOLERABILITY
PHARMACEUTICAL COMPOSITION FOR TOPICAL USE IN THE TREATMENT OF THE CAPILLARY FRAGILITY
PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION
PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL DELIVERY
PHARMACEUTICAL COMPOSITION FOR TREATING ACNE
PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE DYSPHONIA
PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE RHINITIS
PHARMACEUTICAL COMPOSITION FOR TREATING AIDS
PHARMACEUTICAL COMPOSITION FOR TREATING ANGIOCARDIOPATHY AND THE METHOD OF PRODUCING THEREOF
PHARMACEUTICAL COMPOSITION FOR TREATING CARDIOVASCULAR DISEASES CONTAINING 3-(2,2,2-TRIMETHYLHYDRAZINIUM)PROPIONATE AND .GAMMA.-BUTYROBETAINE
PHARMACEUTICAL COMPOSITION FOR TREATING DYSMENORRHEA AND PREMATURE LABOR
PHARMACEUTICAL COMPOSITION FOR TREATING FECAL INCONTINENCE
PHARMACEUTICAL COMPOSITION FOR TREATING GASTROESOPHAGEAL REFLUX
PHARMACEUTICAL COMPOSITION FOR TREATING GASTROINTESTINAL DISEASE
PHARMACEUTICAL COMPOSITION FOR TREATING HEPATITIS B VIRUS (HBV) INFECTION
PHARMACEUTICAL COMPOSITION FOR TREATING MUCOVISCIDOSIS AND CHRONIC PAIN SYNDROMES DERIVING FROM DEGENERATIVE LOCOMOTOR DISEASES OR TUMOROUS ORIGIN
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ALLERGIC RHINITIS
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLUENZA, AND NOVEL CAPPED OLIGONUCLEOTIDE
PHARMACEUTICAL COMPOSITION FOR TREATING OSTEOPOROSIS
PHARMACEUTICAL COMPOSITION FOR TREATING PERIPHERAL CIRCULATION DISORDERS
PHARMACEUTICAL COMPOSITION FOR TREATING THERMAL INJURIES OF WARM BLOODED MAMMALS INCLUDING HUMANS
PHARMACEUTICAL COMPOSITION FOR TREATING VIRAL DISEASES
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ADULT RESPIRATORY DISTRESS SYNDROME CONTAINING HUMAN ANP
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEMENTIA
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HEPATIC DISEASES
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF OSTEOPOROSIS
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SUDDEN DEAFNESS
PHARMACEUTICAL COMPOSITION FOR USE AS A RETINAL PIGMENT EPITHELIAL CELL GROWTH AGENT
PHARMACEUTICAL COMPOSITION FOR USE IN GLAUCOMA TREATMENT
PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF DIABETIC NEUROPATHY
PHARMACEUTICAL COMPOSITION HAVING AN ANTITUMOR ACTIVITY AND A PROCESS FOR PREPARATION THEREOF
PHARMACEUTICAL COMPOSITION HAVING AN ENDOPROTEOLYTIC ACTIVITY
PHARMACEUTICAL COMPOSITION HAVING AN ENDOPROTEOLYTIC ACTIVITY; A PROCESS FOR ENDOPROTEOLYTICALLY PROCESSING (PRECURSOR) PROTEINS AND FOR THE (MICRO)BIOLOGICAL PRODUCTION OF PROTEINS
PHARMACEUTICAL COMPOSITION HAVING ANALGESIC ACTIVITY
PHARMACEUTICAL COMPOSITION HAVING ANTIACOHOLIC ACTIVITY
PHARMACEUTICAL COMPOSITION HAVING ANTIVIRAL AND ANTIBACTERIAL ACTIVITY AND METHOD OF ADMINISTRATION
PHARMACEUTICAL COMPOSITION HAVING ENHANCED ANTITUMOR ACTIVITY AND/OR REDUCED SIDE EFFECTS, CONTAINING AN ANTITUMOR AGENT AND AN HYDROXIMIC ACID DERIVATIVE
PHARMACEUTICAL COMPOSITION HAVING ENHANCED ANTITUMOR ACTIVITY AND/OR REDUCED SIDE EFFECTS, CONTAINING AN ANTITUMOR AGENT AND AN HYDROXLMIC ACID DERIVATIVE
PHARMACEUTICAL COMPOSITION HAVING SITE-SPECIFIC DELIVERY
PHARMACEUTICAL COMPOSITION HAVING THROMBOLYTIC ACTIVITY
PHARMACEUTICAL COMPOSITION HAVING TWO COATING LAYERS
PHARMACEUTICAL COMPOSITION IN A FORM OF SELF-EMULSIFYING FORMULATION FOR LIPOPHILIC COMPOUNDS
PHARMACEUTICAL COMPOSITION IN FORM OF SOLID LIPIDIC MICROPARTICLES SUITABLE TO PARENTERAL ADMINISTRATION
PHARMACEUTICAL COMPOSITION IN GEL FORM IN A DISPENSING PACKAGE
PHARMACEUTICAL COMPOSITION IN THE FORM OF MICROPARTICLES
PHARMACEUTICAL COMPOSITION OF 2-(4-ISOBUTYLPHENYL) PROPIONIC ACID
PHARMACEUTICAL COMPOSITION OF 7-((SUBSTITUTED)AMINO-8-((SUBSTITUTED)CARBONYL)-(METHYLAMINO)-1-OXASP IRO(4,5)DECANES AND L-DOPA
PHARMACEUTICAL COMPOSITION OF ACTIVITY IN THE TREATMENT OF COGNITIVE AND/OR NEUROIMMUNE DYSFUNCTIONS
PHARMACEUTICAL COMPOSITION OF ASPIRIN AND A BENZOTHIAZEPINE FOR INHIBITING PLATELET AGGREGATION
PHARMACEUTICAL COMPOSITION OF BENZOPYRANES FOR THE INHIBITION OF BONE RESORPTION
PHARMACEUTICAL COMPOSITION OF BOTULINUM NEUROTOXIN AND METHOD OF PREPARATION
PHARMACEUTICAL COMPOSITION OF BUF-5 FOR TREATING ANEMIA
PHARMACEUTICAL COMPOSITION OF COMPLEX CARBOHYDRATES AND ESSENTIAL OILS AND METHODS OF USING THE SAME
PHARMACEUTICAL COMPOSITION OF ESCHERICHIA COLI HEAT-LABILE ENTEROTOXIN ADJUVANT AND METHODS OF USE
PHARMACEUTICAL COMPOSITION OF F(AB1)2 ANTIBODY FRAGMENTS AND A PROCESS FOR THE PREPARATION THEREOF
PHARMACEUTICAL COMPOSITION OF FLORFENICOL
PHARMACEUTICAL COMPOSITION OF HERPES SIMPLEX VIRUS TYP-1 (HSV-1) GLYCOPROTEINS
PHARMACEUTICAL COMPOSITION OF L-DOPA ESTER
PHARMACEUTICAL COMPOSITION OF LAMOTRIGINE
PHARMACEUTICAL COMPOSITION OF PURIFIED CHYMOPAPAIN
PHARMACEUTICAL COMPOSITION OF STABILIZED [LEU.SUP.13 ]-MOTILIN-HSE
PHARMACEUTICAL COMPOSITION OF THE INTERCELLULAR ADHESION MOLECULE ICAM-1 FOR USE IN ANTI-VIRAL PROPHYLACTIC THERAPY
PHARMACEUTICAL COMPOSITION OF TICLOPIDINE HYDROCHLORIDE | PHARMACEUTICAL COMPOSITION OF TOPIRAMATE
PHARMACEUTICAL COMPOSITION PREPARATION FOR USE IN INHIBITING PROTEIN KINASE C
PHARMACEUTICAL COMPOSITION PREPARED BY ADDITION OF A FLAVOR VEHICLE TO A MEDICAMENT
PHARMACEUTICAL COMPOSITION REGULATING FUNCTION OF A LIVING BODY
PHARMACEUTICAL COMPOSITION SUITABLE FOR STIMULATING THE MULTIPLICATION AND GROWTH OF OSTEOBLASTS
PHARMACEUTICAL COMPOSITION TO ENHANCE TISSUE HEALING AND REGENERATION AND APPLICATION KIT COMPRISING IT
PHARMACEUTICAL COMPOSITION USEFUL FOR NUCLEIC ACID TRANSFECTION, AND USE THEREOF
PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF TINNITUS AND HEARING LOSS
PHARMACEUTICAL COMPOSITION USEFUL FOR TREATING OPHTHALMOLOGICAL DISEASES
PHARMACEUTICAL COMPOSITION USING A MIXTURE OF PROPELLANT GASES FOR A METERED DOSE INHALER
PHARMACEUTICAL COMPOSITION WHICH CONTAINS A RENIN ANGIOTENSIN SYSTEM INHIBITOR AND AN ENDOTHELIN ANTAGONIST
PHARMACEUTICAL COMPOSITION WHICH IS STABLE DURING STORAGE AND CONTAINS A THYMUS EXTRACT
PHARMACEUTICAL COMPOSITION WITH A SYNTHETIC NATURAL PROGESTERONE AND OESTRADIOL BASE AND ITS PREPARATION PROCESS
PHARMACEUTICAL COMPOSITION WITH ANAESTHETIC EFFECT
PHARMACEUTICAL COMPOSITION WITH ANTITUMOR ACTIVITY ON THE BASIS OF CARBOPLATIN
PHARMACEUTICAL COMPOSITION WITH ANTIVIRAL ACTIVITY CONTAINING AN HYDROXYMIC ACID DERIVATIVE AND AN ANTIVIRAL AGENT
PHARMACEUTICAL COMPOSITION WITH EXTENDED RELEASE OF MILNACIPRAN
PHARMACEUTICAL COMPOSITION WITH IMPROVED BIOAVAILABILITY OF INOSITOL PHOSPHATE
PHARMACEUTICAL COMPOSITION WITH IMPROVED DISSOLUTION PROPERTY
PHARMACEUTICAL COMPOSITION WITH LOW TOXICITY FOR ANTI-INFLAMMATION AND ANTI-EXUDATION
PHARMACEUTICAL COMPOSITION WITH SOTALOL COMBINATION AND THEIR USE IN TREATMENT OF CARDIAC AILMENTS
PHARMACEUTICAL COMPOSITION WITH TUMOR NECROSIS FACTOR A AND 2-METHOXYESTRONE-3-0-SULPHAMATE FOR INHIBITION OF ESTRONE SULPHATASE
PHARMACEUTICAL COMPOSITION, CONTAINING MEDIUM-CHAIN FATTY ACIDS AS ACTIVE INGREDIENTS, FOR DENTAL CARIES AND PERIODONTAL DISEASE
PHARMACEUTICAL COMPOSITIONS
PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS
PHARMACEUTICAL COMPOSITIONS ACTIVE ON THE CARDIOVASCULAR SYSTEM, CONTAINING 3-METHYLTHIOPROPIONYL L-CARNITINE
PHARMACEUTICAL COMPOSITIONS AGAINST GASTRIC DISORDERS
PHARMACEUTICAL COMPOSITIONS AGAINST SEVERAL HERPES VIRUS INFECTIONS AND/OR ATHEROSCLEROTIC PLAQUE
PHARMACEUTICAL COMPOSITIONS AND A DEVICE FOR ADMINISTERING THE SAME
PHARMACEUTICAL COMPOSITIONS AND A METHOD FOR THE TREATMENT OF MEMORY DISORDERS, INTELLECTUAL DISORDERS OF AGEING AND ALZHEIMER'S DISEASE
PHARMACEUTICAL COMPOSITIONS AND DEVICES FOR THEIR ADMINISTRATION
PHARMACEUTICAL COMPOSITIONS AND DIETARY SOYBEAN FOOD PRODUCTS FOR THE PREVENTION OF OSTEOPOROSIS
PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR THE ORAL ADMINISTRATION OF CALCITONIN
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR ADMINISTERING 3 AND 4-SUBSTITUTED 2(5H)-FURANONES TO A MAMMAL FOR INHIBITING BONE LOSS
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR PROPHYLAXIS AND THERAPY OF RADICAL-MEDIATED CELL DAMAGE
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE INHIBITION AND TREATMENT OF SECONDARY HYPERTENSION
PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING SAME
PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING SAME FOR THE TREATMENT OF FAILING MYOCARDIAL TISSUE
PHARMACEUTICAL COMPOSITIONS AND METHODS
PHARMACEUTICAL COMPOSITIONS AND METHODS EMPLOYING CAMPTOTHECINS
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR EFFECTING DOPAMINE RELEASE
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR IMPROVING WRINKLES AND OTHER SKIN CONDITIONS
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MANAGING SCALP CONDITIONS
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MANAGING SKIN CONDITIONS
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MODULATING SIGNAL TRANSDUCTION
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PRODUCING ANTIBODIES TO HEPATITIS B VIRUS AND KITS AND METHODS FOR DETECTING ANTIBODIES TO HEPATITIS B VIRUS
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PROTECTING AND TREATING SUN DAMAGED SKIN
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR REDUCING THE APPEARANCE OF CELLULITE
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF ARTERIOSCLEROSIS
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING ACNE
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING ANXIETY, ANXIETY DISORDERS AND MEMORY IMPAIRMENT USING NAALADASE INHIBITORS
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING COMPULSIVE DISORDERS USING PYRROLIDINE DERIVATIVES
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING IMMUNE-RESPONSE ASSOCIATED DISEASES OF THE SURFACE AND THE ANTERIOR SEGMENT OF THE EYE
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING THE SYMPTOMS OF OVERINDULGENCE
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF CANCER
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
PHARMACEUTICAL COMPOSITIONS AND METHODS OF EFFECTING A NEURONAL ACTIVITY IN AN ANIMAL USING NAALADASE INHIBITORS
PHARMACEUTICAL COMPOSITIONS AND METHODS OF INHIBITING ANGIOGENESIS USING NAALADASE INHIBITORS
PHARMACEUTICAL COMPOSITIONS AND METHODS OF SULPHONAMIDES CONTAINING A TETRAZOLYL RADICAL
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TRANSPORTING COMPOUNDS ACROSS BIOLOGICAL MEMBRANE
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING A GLUTAMATE ABNORMALITY AND EFFECTING A NEURONAL ACTIVITY IN AN ANIMAL USING NAALADASE INHIBITORS
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT OF THE CORNEA FOLLOWING LASER IRRADIATION
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT OF THE CORNEA FOLLOWING LASER TREATMENT
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT OF THE CORNEA FOLLOWING ULTRAVIOLET LASER IRRADIATION
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT OF THE CORNEA IN CONJUNCTION WITH LASER IRRADIATION
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT OF THE CORNEAL FOLLOWING LASER IRRADIATION
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT TO PREVENT AND TREAT CORNEAL SCAR FORMATION PRODUCED BY LASER IRRADIATION
PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING NICOTINIC ANTAGONISTS FOR TREATING A CONDITION OR DISORDER CHARACTERIZED BY ALTERATION IN NORMAL NEUROTRANSMITTER RELEASE
PHARMACEUTICAL COMPOSITIONS AND METHODS USING ISOBUTYRAMIDE FOR TREATING BETAGLOBIN DISORDERS
PHARMACEUTICAL COMPOSITIONS AND PROCESS OF MANUFACTURE THEREOF
PHARMACEUTICAL COMPOSITIONS AND THEIR USE
PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF PARASITOSES
PHARMACEUTICAL COMPOSITIONS AND THEIR USE, NAMELY FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS
PHARMACEUTICAL COMPOSITIONS AND TREATMENT METHODS
PHARMACEUTICAL COMPOSITIONS AND USAGES
PHARMACEUTICAL COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PSORIASIS
PHARMACEUTICAL COMPOSITIONS AND USE THEREOF IN TREATING INFLAMMATION
PHARMACEUTICAL COMPOSITIONS AND USES OF INORGANIC PYROPHOSPHATES
PHARMACEUTICAL COMPOSITIONS AND USES OF WATER-SOLUBLE, HIGH-VISCOSITY GRADE CELLULOSE ETHERS
PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND ENDOTHELIN ANTAGONISTS
PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND NK1-RECEPTOR ANTAGONISTS
PHARMACEUTICAL COMPOSITIONS BASED ON CHEWING GUM AND A METHOD FOR THE PREPARATION THEREOF
PHARMACEUTICAL COMPOSITIONS BASED ON DALFOPRISTINE AND ON QUINUPRISTINE, AND PREPARATION THEREOF
PHARMACEUTICAL COMPOSITIONS BASED ON EBASTINE OR ANALOGUES THEREOF
PHARMACEUTICAL COMPOSITIONS BASED ON MEQUITAZINE
PHARMACEUTICAL COMPOSITIONS CAPABLE OF BEING GELLED
PHARMACEUTICAL COMPOSITIONS COMPRISED OF STABILIZED PEPTIDE PARTICLES
PHARMACEUTICAL COMPOSITIONS COMPRISING 2-ISOXAZOLES-8-AMINOTETRALIN DERIVATIVES
PHARMACEUTICAL COMPOSITIONS COMPRISING 2-QUINOLONES
PHARMACEUTICAL COMPOSITIONS COMPRISING 3-AMINO-.EPSILON.-CAPROLACTAMES FOR ENHANCING THE PROCESS OF LEARNING AND MEMORY
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-QUINOLONES FOR TREATING CANCERS
PHARMACEUTICAL COMPOSITIONS COMPRISING A SOLUBLE INTERLEUKIN-4 RECEPTOR
PHARMACEUTICAL COMPOSITIONS COMPRISING ALKANOYL L-CARNITINE IN COMBINATION WITH A STATINE FOR TREATING PATHOLOGIES BROUGHT ABOUT BY AN ALTERED LIPID METABOLISM
PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALDOSE REDUCTASE INHIBITOR AND AN ACE INHIBITOR
PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTICYTOKINE
PHARMACEUTICAL COMPOSITIONS COMPRISING AN OPIATE ANTAGONIST AND CALCIUM SALTS, THEIR USE FOR THE TREATMENT OF ENDORPHIN-MEDIATED PATHOLOGIES
PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-CD45RB ANTIBODIES FOR THE INHIBITION OF T-CELL MEDIATED IMMUNE RESPONSES
PHARMACEUTICAL COMPOSITIONS COMPRISING CALCITONIN FOR INTRANASAL ADMINISTRATION
PHARMACEUTICAL COMPOSITIONS COMPRISING CLIOQUINOL IN COMBINATION WITH VITAMIN B12 AND THERAPEUTIC AND PROPHYLACTIC USES THEREOF
PHARMACEUTICAL COMPOSITIONS COMPRISING CLOZAPINE AND A RADICAL SCAVENGER
PHARMACEUTICAL COMPOSITIONS COMPRISING CO-MICRONIZED FENOFIBRATE
PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLOSPORINS
PHARMACEUTICAL COMPOSITIONS COMPRISING DISULFIRAM
PHARMACEUTICAL COMPOSITIONS COMPRISING ERYTHROPOIETIN FOR TREATMENT OF CANCER
PHARMACEUTICAL COMPOSITIONS COMPRISING ESTERS OR AMIDES AS ACTIVE INGREDIENTS
PHARMACEUTICAL COMPOSITIONS COMPRISING FLUORINATED CO-POLYMERS
PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN INTERLEUKIN-4 (IL-4)
PHARMACEUTICAL COMPOSITIONS COMPRISING HYBRID .ALPHA.-INTERFERON
PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROXAMATE DERIVATIVES FOR IRON REMOVAL
PHARMACEUTICAL COMPOSITIONS COMPRISING ISOVALERAMIDE
PHARMACEUTICAL COMPOSITIONS COMPRISING LABDANE DITERPENOID DERIVATIVES AND PYRIMIDO(6,1-A)ISOQUINOLIN-4-ONE DERIVATIVES AND THEIR USE
PHARMACEUTICAL COMPOSITIONS COMPRISING METAL COMPLEXES
PHARMACEUTICAL COMPOSITIONS COMPRISING METHANEDIPHOSPHONIC ACID DERIVATIVES AND MACROCYCLIC POLYETHERS
PHARMACEUTICAL COMPOSITIONS COMPRISING MODIFIED AND UNMODIFIED PLASMINOGEN ACTIVATORS
PHARMACEUTICAL COMPOSITIONS COMPRISING MOEXIPRIL MAGNESIUM
PHARMACEUTICAL COMPOSITIONS COMPRISING NEUROTROPHIC PEPTIDES DERIVED FROM PROSAPOSIN
PHARMACEUTICAL COMPOSITIONS COMPRISING NOVEL OLIGOPEPTIDES EXHIBITING SELECTIVE INHIBITING EFFECT UPON THE PROLIFERATION OF HEMOPOIETIC CELLS
PHARMACEUTICAL COMPOSITIONS COMPRISING ORGANIC POLYMERS CONTAINING INORGANIC ANIONIC GROUPS AND METHOD OF PROPHYLAXIS AND TREATMENT OF RETROVIRUS INFECTIONS IN MAMMALS USING SAID COMPOSITIONS
PHARMACEUTICAL COMPOSITIONS COMPRISING PARACETAMOL AND L-CYSTEINE OR A PRECURSOR THEREOF
PHARMACEUTICAL COMPOSITIONS COMPRISING PHOSPHATIDYL CARNITINE FOR THE TREATMENT OF HUMAN PATHOLOGIES ASSOCIATED WITH NEURONAL DAMAGE
PHARMACEUTICAL COMPOSITIONS COMPRISING PHOSPHITE-BORANE COMPOUNDS
PHARMACEUTICAL COMPOSITIONS COMPRISING PLURIPOTENT GRANULOCYTE COLONY-STIMULATING FACTOR
PHARMACEUTICAL COMPOSITIONS COMPRISING POLY-.BETA.-1.FWDARW.4-N-ACETYLGLUCOSAMINE
PHARMACEUTICAL COMPOSITIONS COMPRISING PORPHYRINS AND SOME NOVEL PORPHYRIN DERIVATIVES
PHARMACEUTICAL COMPOSITIONS COMPRISING POTASSIUM CLAVULANATE AND METHODS OF USING THEM
PHARMACEUTICAL COMPOSITIONS COMPRISING QUINAPRIL MAGNESIUM
PHARMACEUTICAL COMPOSITIONS COMPRISING QUINAZOLIN-4-ONE DERIVATIVES
PHARMACEUTICAL COMPOSITIONS COMPRISING RAFAMYCIN COPRECIPITATES
PHARMACEUTICAL COMPOSITIONS COMPRISING RECOMBINANT BPI PROTEINS AND A LIPID CARRIER AND USES THEREOF
PHARMACEUTICAL COMPOSITIONS COMPRISING RECOMBINANT TROPONIN SUBUNITS
PHARMACEUTICAL COMPOSITIONS COMPRISING S-(-)-N-PROPARGYL-1-AMINOINDAN
PHARMACEUTICAL COMPOSITIONS COMPRISING S-ALKYLISOTHIOURONIUM DERIVATIVES
PHARMACEUTICAL COMPOSITIONS COMPRISING SELECTED LACTOBACILLUS STRAINS
PHARMACEUTICAL COMPOSITIONS COMPRISING SYNTHETIC PEPTIDE COPOLYMER FOR PREVENTION OF GVHD
PHARMACEUTICAL COMPOSITIONS COMPRISING TETRAHYDROPYRIMIDINE DERIVATES
PHARMACEUTICAL COMPOSITIONS COMPRISING TEXAPHYRINS
PHARMACEUTICAL COMPOSITIONS COMPRISING TGF-BETA
PHARMACEUTICAL COMPOSITIONS COMPRISING THIRAM
PHARMACEUTICAL COMPOSITIONS COMPRISING THROMBIN INHIBITORS AND THEIR USE IN THE CONTROL OF WOUND HEALING PROCESSES
PHARMACEUTICAL COMPOSITIONS COMPRISING TROPONIN SUBUNITS, FRAGMENTS AND ANALOGS THEREOF AND METHODS OF THEIR USE TO INHIBIT ANGIOGENESIS
PHARMACEUTICAL COMPOSITIONS COMPRISING TROPONIN SUBUNITS, FRAGMENTS AND HOMOLOGS THEREOF AND METHODS OF THEIR USE TO INHIBIT ANGIOGENESIS
PHARMACEUTICAL COMPOSITIONS COMPRISING TYRPHOSTINS
PHARMACEUTICAL COMPOSITIONS CONTAINING (65)-FOLINIC ACID AND SALTS THEREOF
PHARMACEUTICAL COMPOSITIONS CONTAINING 1-OLEYLAZACYCLOHEPTAN-2-ONE AS ENHANCING AGENT OF TRANSPORT ACROSS BIOLOGICAL MEMBRANES
PHARMACEUTICAL COMPOSITIONS CONTAINING 3-AMINOAZETIDINE DERIVATIVES, NOVEL DERIVATIVES AND THEIR PREPARATION
PHARMACEUTICAL COMPOSITIONS CONTAINING 3-BETA-HYDROXYLATED 6,7-SUBSTITUTED STEROID DERIVATIVES, AND USE THEREOF
PHARMACEUTICAL COMPOSITIONS CONTAINING 3-IODO-1,2-PROPANEDIOL HAVING MUCOLYTIC ACTIVITY
PHARMACEUTICAL COMPOSITIONS CONTAINING 4-SUBSTITUTED IMIDAZOLES TO BE ADMINISTERED TRANSDERMALLY
PHARMACEUTICAL COMPOSITIONS CONTAINING 5'-DEOXY-5'-METHYLTHIOADENOSINE S-ADENOSYLMETHIONINE AND THEIR SALTS FOR REDUCING SEBORRHEA
PHARMACEUTICAL COMPOSITIONS CONTAINING A 4, 5-DIHYDRO-1, 3-THIAZOL-2-YLAMINE DERIVATIVE, NOVEL DERIVATIVES AND PREPARATION THEREOF
PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
PHARMACEUTICAL COMPOSITIONS CONTAINING A DERIVATIVE OF 3-HYDROXYBUTANOIC ACID CHOSEN FROM OLIGOMERS OF THIS ACID AND ESTERS OF THIS ACID OR OF THESE OLIGOMERS WITH 1,3-BUTANEDIOL
PHARMACEUTICAL COMPOSITIONS CONTAINING A FLUOROQUINOLONE ANTIBIOTIC DRUG AND XANTHAN GUM
PHARMACEUTICAL COMPOSITIONS CONTAINING A STAUROSPORINE
PHARMACEUTICAL COMPOSITIONS CONTAINING A SUPEROXIDE DISMUTASE
PHARMACEUTICAL COMPOSITIONS CONTAINING ACTH (1-24) FOR THE THERAPY OF SHOCK CONDITIONS AND RESPIRATORY AND CARDIOCIRCULATORY INSUFFICIENCES
PHARMACEUTICAL COMPOSITIONS CONTAINING ALKYLARYL POLYETHER ALCOHOL POLYMER
PHARMACEUTICAL COMPOSITIONS CONTAINING AMETHOCAINE
PHARMACEUTICAL COMPOSITIONS CONTAINING AMISULPRIDE AND THEIR THERAPEUTIC APPLICATIONS
PHARMACEUTICAL COMPOSITIONS CONTAINING AMYLIN
PHARMACEUTICAL COMPOSITIONS CONTAINING AN EFFERVESCENT ACID-BASE COUPLE
PHARMACEUTICAL COMPOSITIONS CONTAINING AN OMEGA-3 FATTY ACID OIL
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-FAS ANTIBODY
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBODIES TO AMYLIN
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBODY-ENZYME CONJUGATES IN COMBINATION WITH PRODRUGS
PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE SUBSTANCE SULPHUR-CONTAINING CARBOXYLIC ACIDS AND THEIR USE IN COMBATING RETROVIRUSES
PHARMACEUTICAL COMPOSITIONS CONTAINING AT LEAST ONE NSAID HAVING INCREASED BIOAVAILABILITY
PHARMACEUTICAL COMPOSITIONS CONTAINING AZETIDINE DERIVATIVES, NOVEL AZETIDINE DERIVATIVES AND THEIR PREPARATION
PHARMACEUTICAL COMPOSITIONS CONTAINING BICYCLOHEPTANE ETHER AMINES AND A PROCESS FOR THE PREPARATION THEREOF
PHARMACEUTICAL COMPOSITIONS CONTAINING BRETAZENIL AND METHODS OF USING THEM
PHARMACEUTICAL COMPOSITIONS CONTAINING BUFFERED ORTHO ESTER POLYMERS
PHARMACEUTICAL COMPOSITIONS CONTAINING CALCITONIN GENE-RELATED PEPTIDE (CGRP) AND USE THEREOF TO AMELIORATE HYPERIMMUNE MEDIATED DISEASES AND ABNORMAL CONDITIONS
PHARMACEUTICAL COMPOSITIONS CONTAINING CALCITONIN IN A SPRAY DOSING FEEDER FOR INTRANASAL ADMINISTRATION
PHARMACEUTICAL COMPOSITIONS CONTAINING CARVEDILOL AND HYDROCHLOROTHIAZIDE
PHARMACEUTICAL COMPOSITIONS CONTAINING CEFTRIAXONE AND PENEMS
PHARMACEUTICAL COMPOSITIONS CONTAINING CERTAIN DIARYLIMIDAZOLE DERIVATIVES
PHARMACEUTICAL COMPOSITIONS CONTAINING CHONDROITINASE AND USES THEREFOR
PHARMACEUTICAL COMPOSITIONS CONTAINING CINCHONINE DICHLORHYDRATE
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORIN
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORIN AS THE ACTIVE AGENT
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINE AND A CARRIER COMPRISING AT LEAST AN ESTER OF .ALPHA.-GLYCEROPHOSPHORIC ACID
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS
PHARMACEUTICAL COMPOSITIONS CONTAINING D.SUB.2 O
PHARMACEUTICAL COMPOSITIONS CONTAINING DEOXYRIBONUCLEOSIDES FOR WOUND HEALING
PHARMACEUTICAL COMPOSITIONS CONTAINING DI-PHOSPHONIC ACID AMIDINES
PHARMACEUTICAL COMPOSITIONS CONTAINING DIDEMNINS
PHARMACEUTICAL COMPOSITIONS CONTAINING DIPYRIDAMOLE OR MOPIDAMOL AND ACETYLSALICYLIC ACID OR THE PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, PROCESSES FOR PREPARING THEM AND THEIR USE IN TREATING CLOT FORMATION
PHARMACEUTICAL COMPOSITIONS CONTAINING DONEPEZIL HYDROCHLORIDE
PHARMACEUTICAL COMPOSITIONS CONTAINING DRUGS WHICH ARE INSTABLE OR SPARINGLY SOLUBLE IN WATER AND METHODS FOR THEIR PREPARATION
PHARMACEUTICAL COMPOSITIONS CONTAINING ECOTIN AND HOMOLOGS THEREOF
PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTRAN HEMISULPHATE AND CAFFEINE
PHARMACEUTICAL COMPOSITIONS CONTAINING FAMOTIDINE AND ALUMINUM HYDROXIDE OR MAGNESIUM HYDROXIDE
PHARMACEUTICAL COMPOSITIONS CONTAINING FIBROBLAST GROWTH FACTOR-RELATED PEPTIDES
PHARMACEUTICAL COMPOSITIONS CONTAINING FLAVANOLIGNANES AND METHODS FOR USING SAME AS AN ANTIPROLIFERATIVE
PHARMACEUTICAL COMPOSITIONS CONTAINING FURAN DERIVATIVES
PHARMACEUTICAL COMPOSITIONS CONTAINING GEMINAL DIPHOSPHONATES
PHARMACEUTICAL COMPOSITIONS CONTAINING GIROXINA AND PHOSPHOLIPASE A.SUB.2 AND METHODS OF INCREASING A PATIENT'S CD.SUB.4 COUNT USING THE PHARMACEUTICAL COMPOSITIONS
PHARMACEUTICAL COMPOSITIONS CONTAINING GRANISETRON AND DEXAMETHASONE
PHARMACEUTICAL COMPOSITIONS CONTAINING HEDGEHOG PROTEIN
PHARMACEUTICAL COMPOSITIONS CONTAINING HERBAL-BASED ACTIVE INGREDIENTS; METHODS FOR PREPARING SAME AND USES OF SAME FOR MEDICAL AND VETERINARY PURPOSES
PHARMACEUTICAL COMPOSITIONS CONTAINING HIV PROTEASE INHIBITORS AND METHODS OF THEIR USE
PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACID FRACTIONS
PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROXIMIC ACID DERIVATIVES
PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROXYCARBOXYLIC ACID AND/OR KETOCARBOXYLIC ACIDS AND METHODS OF USING THE SAME
PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROXYCARBOXYLIC ACIDS AND/OR KETOCARBOXYLIC ACIDS AND METHODS OF USING SAME
PHARMACEUTICAL COMPOSITIONS CONTAINING IL-6
PHARMACEUTICAL COMPOSITIONS CONTAINING IN COMBINATION TWO ANTAGONISTS SELECTIVE OF ARGININE-VASSOPRESSIN V RECEPTORS, EVEN OF V1 A AND V2 RECEPTORS
PHARMACEUTICAL COMPOSITIONS CONTAINING INSOLUBLE CALCIUM SALTS OF AMINO-HYDROXYBUTYLIDENE BISPHOSHONIC ACIDS
PHARMACEUTICAL COMPOSITIONS CONTAINING INTERDIGITATION-FUSION LIPOSOMES AND GELS
PHARMACEUTICAL COMPOSITIONS CONTAINING INTERFERONS AND FATTY ACIDS
PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCESS FOR THE PREPARATION THEREOF AND RELATIVE THERAPEUTIC USE
PHARMACEUTICAL COMPOSITIONS CONTAINING IRBESARTAN
PHARMACEUTICAL COMPOSITIONS CONTAINING ISOQUINOLINE DERIVATIVES
PHARMACEUTICAL COMPOSITIONS CONTAINING KUKUI NUT OIL
PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILLI FOR TREATMENT OF VAGINAL INFECTIONS AND RELATED METHOD
PHARMACEUTICAL COMPOSITIONS CONTAINING LAMIVUDINE
PHARMACEUTICAL COMPOSITIONS CONTAINING LIPASE INHIBITOR
PHARMACEUTICAL COMPOSITIONS CONTAINING LOW MOLECULAR WEIGHT DERMATAN SULFATE FOR THE THERAPY OF PULMONARY EMBOLISM
PHARMACEUTICAL COMPOSITIONS CONTAINING MESEMBRINE AND RELATED COMPOUNDS
PHARMACEUTICAL COMPOSITIONS CONTAINING MONOSIALOGANGLIOSIDE GM1 OR DERIVATIVE THEREOF SUITABLE FOR THE TREATMENT OF PARKINSON'S DISEASE
PHARMACEUTICAL COMPOSITIONS CONTAINING MUPIROCIN
PHARMACEUTICAL COMPOSITIONS CONTAINING N-(3,4-DIMETHOXYCINNAMOYL) ANTHRANILIC ACID
PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYL-CYSTEINE DERIVATIVES USEFUL FOR THE TREATMENT OF CATARACT
PHARMACEUTICAL COMPOSITIONS CONTAINING N-PALMITOYLETHANOLAMIDE AND USE THEREOF IN THE VETERINARY FIELD
PHARMACEUTICAL COMPOSITIONS CONTAINING N-PROPARGYLPHENTERMINE AND RELATED ANALOGS TO TREAT NEURODEGENERATION AND/OR DEPRESSION
PHARMACEUTICAL COMPOSITIONS CONTAINING NANOCAPSULES
PHARMACEUTICAL COMPOSITIONS CONTAINING NIFEDIPINE AND PROCESS FOR THE PREPARATION THEREOF
PHARMACEUTICAL COMPOSITIONS CONTAINING NON-RACEMIC VERAPAMIL AND PROCESS FOR OPTIMIZING THE PHARMACEUTICAL ACTIVITY OF R- AND S-VERAPAMIL
PHARMACEUTICAL COMPOSITIONS CONTAINING OCTREOTIDE AND EXCIPIENTS FOR ORAL OR RECTAL ADMINISTRATION
PHARMACEUTICAL COMPOSITIONS CONTAINING OLIGOSACCHARIDES, THE NOVEL OLIGOSACCHARIDES AND PREPARATION THEREOF
PHARMACEUTICAL COMPOSITIONS CONTAINING ORALLY ABSORBABLE GLYCOSAMIMOGLYCANS
PHARMACEUTICAL COMPOSITIONS CONTAINING PACLITAXEL
PHARMACEUTICAL COMPOSITIONS CONTAINING PARTHENIUM INTEGRIFOLIUM OR PARTS THEREOF OR AN EXTRACT OR COMPONENT THEREOF, THE USE OF SUCH PLANT MATERIAL FOR PREPARING CERTAIN MEDICINES, AND A METHOD OF PREPARING AN EXTRACT OF PARTHENIUM INTEGRIFOLIUM
PHARMACEUTICAL COMPOSITIONS CONTAINING PENTAMIDINE
PHARMACEUTICAL COMPOSITIONS CONTAINING PHENYLAMIDES
PHARMACEUTICAL COMPOSITIONS CONTAINING PHOSPHOLIPASE INHIBITOR
PHARMACEUTICAL COMPOSITIONS CONTAINING PHYTIC ACID OR ITS SALTS
PHARMACEUTICAL COMPOSITIONS CONTAINING PLASMA PROTEIN
PHARMACEUTICAL COMPOSITIONS CONTAINING POLYALKYLENE BLOCK COPOLYMERS WHICH GEL AT PHYSIOLOGICAL TEMPERATURE
PHARMACEUTICAL COMPOSITIONS CONTAINING POLYMER DERIVATIVE-BOUND ANTHRACYCLINE GLYCOSIDES AND A METHOD FOR THEIR PREPARATION
PHARMACEUTICAL COMPOSITIONS CONTAINING PROLACTIN AND METHODS FOR THE USE THEREOF
PHARMACEUTICAL COMPOSITIONS CONTAINING PROPYLENE GLYCOL AND/OR POLYETHYLENE GLYCOL AND UREA AS ACTIVE MAIN COMPONENTS AND USE THEREOF
PHARMACEUTICAL COMPOSITIONS CONTAINING PROTEINASE INHIBITORS
PHARMACEUTICAL COMPOSITIONS CONTAINING PYRYLIUM COMPOUNDS, PYRYLIUM SALTS AND PROCESS FOR MANUFACTURING A MEDICAMENT CONTAINING THE AFORESAID COMPOUNDS
PHARMACEUTICAL COMPOSITIONS CONTAINING R-.ALPHA.-LIPOIC ACID OR S-.ALPHA.-LIPOIC ACID AS ACTIVE INGREDIENT
PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMIN FOR TREATMENT OF VAGINAL INFECTIONS | PHARMACEUTICAL COMPOSITIONS CONTAINING SUPEROXIDE DISMUTASE FROM BACILLUS STEAROTHERMOPHILUS AND BACILLUS CALDOTENAX
PHARMACEUTICAL COMPOSITIONS CONTAINING THE SALTS OF S(+)-2-(4-ISOBUTYLPHENYL)PROPIONIC ACID WITH BASIC AMINOACIDS
PHARMACEUTICAL COMPOSITIONS CONTAINING TOBRAMYCIN AND XANTHAN GUM
PHARMACEUTICAL COMPOSITIONS CONTAINING TRAMADOL FOR MIGRAINE
PHARMACEUTICAL COMPOSITIONS CONTAINING TRIAZOLE DERIVATIVES FOR RECTAL ADMINISTRATION
PHARMACEUTICAL COMPOSITIONS CONTAINING TRIAZOLES AND METHOD OF TREATING ESTROGEN-DEPENDENT DISEASES
PHARMACEUTICAL COMPOSITIONS CONTAINING TRIAZOLONES AND METHODS OF TREATING NEURODEGENERATIVE DISEASE USING TRIAZOLONES
PHARMACEUTICAL COMPOSITIONS CONTAINING TSG-6 FOR TREATING INFLAMMATORY DISEASES AND CANCER-RELATED PATHOLOGIES AND METHOD
PHARMACEUTICAL COMPOSITIONS DERIVED FROM GINSENG AND METHODS OF TREATMENT USING SAME
PHARMACEUTICAL COMPOSITIONS DERIVED FROM MICROEMULSION-BASED GELS
PHARMACEUTICAL COMPOSITIONS DERIVED FROM THE ACID FRACTION OF LIPID EXTRACTS OF SABAL SERRULATA, WITH ADRENERGIC ANTAGONIST ACTIVITY AND METHOD OF PREPARING SAID COMPOSITION
PHARMACEUTICAL COMPOSITIONS FOR AIDING HUMAN DIGESTION
PHARMACEUTICAL COMPOSITIONS FOR BUCCAL AND PULMONARY ADMINISTRATION COMPRISING AN ALKALI METAL ALKYL SULFATE AND AT LEAST THREE MICELLE-FORMING COMPOUNDS
PHARMACEUTICAL COMPOSITIONS FOR BUCCAL AND PULMONARY APPLICATION
PHARMACEUTICAL COMPOSITIONS FOR COMPETITIVELY INHIBITING THE BINDING OF A RETROVIRUS TO THE IFN-RECEPTOR AND MEANS FOR DIAGNOSIS OF AN HIV INFECTION
PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE OF ACTIVE SUBSTANCES
PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE OF SOLUBLE RECEPTORS
PHARMACEUTICAL COMPOSITIONS FOR CONTROLLING UNITARY SMOOTH MUSCLE POLARIZATION
PHARMACEUTICAL COMPOSITIONS FOR CURING RHEUMATISM
PHARMACEUTICAL COMPOSITIONS FOR ELIMINATING MEMBRANE-MEDIATED CELL RESISTANCE
PHARMACEUTICAL COMPOSITIONS FOR FREEZE DRYING
PHARMACEUTICAL COMPOSITIONS FOR IMAGING AND TREATING THROMBI
PHARMACEUTICAL COMPOSITIONS FOR IMMUNOTHERAPY CONTAINING ANTIBODIES WHICH SPECIFICALLY RECOGNIZE THE MHCII ANTIGEN OF A PATIENT TO BE TREATED
PHARMACEUTICAL COMPOSITIONS FOR INHIBITING THE FORMATION OF TUMOR NECROSIS FACTOR
PHARMACEUTICAL COMPOSITIONS FOR INHIBITING THE GROWTH OF CANCERS
PHARMACEUTICAL COMPOSITIONS FOR INHIBITION OF CYTOKINE PRODUCTION AND SECRETION
PHARMACEUTICAL COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF APOMORPHINE
PHARMACEUTICAL COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF CALCITONIN
PHARMACEUTICAL COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF DIHYDROERGOTAMINE
PHARMACEUTICAL COMPOSITIONS FOR INTRANASAL SPRAY ADMINISTRATION OF KETOROLAC TROMETHAMINE
PHARMACEUTICAL COMPOSITIONS FOR MANAGING SCALP CONDITIONS
PHARMACEUTICAL COMPOSITIONS FOR NASAL ADMINISTRATION CONTAINING STEROID HORMONES AND DIMETHYL-.BETA.-CYCLODEXTRIN
PHARMACEUTICAL COMPOSITIONS FOR NEUROPROTECTION CONTAINING ARYLCYCLOHEXYLAMINES
PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION
PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF PHLOROGLUCINOL AND PREPARATION THEREOF
PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION, COMPRISING AN ACTIVE SUBSTANCE AND A CYCLODEXTRIN
PHARMACEUTICAL COMPOSITIONS FOR ORAL USE AND METHOD OF PREPARING THEM
PHARMACEUTICAL COMPOSITIONS FOR ORAL USE INCLUDING AN NSAID AND CERAMIDES
PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL USE CONTAINING A CALCITONIN AS THE ACTIVE INGREDIENT
PHARMACEUTICAL COMPOSITIONS FOR PIPERIDINALKANOL COMPOUNDS
PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS
PHARMACEUTICAL COMPOSITIONS FOR PROLONGED PEPTIDE RELEASE AND PREPARATION METHOD
PHARMACEUTICAL COMPOSITIONS FOR PROMOTING THE GROWTH OF GRAM-POSITIVE BACILLI AND INCREASING THE ACIDITY IN VAGINA AND THE USE THEREOF
PHARMACEUTICAL COMPOSITIONS FOR RECTAL AND VAGINAL ADMINISTRATION
PHARMACEUTICAL COMPOSITIONS FOR REDUCING HYPERLIPIDEMIA AND PLATELET-AGGREGATION
PHARMACEUTICAL COMPOSITIONS FOR REDUCING THE APPEARANCE OF CELLULITE
PHARMACEUTICAL COMPOSITIONS FOR SCARLESS TISSUE REPAIR AND REGENERATION AND METHODS RELATED THERETO
PHARMACEUTICAL COMPOSITIONS FOR THE AMELIORATION OF ENTEROPATHOGENIC E. COLI INFECTION
PHARMACEUTICAL COMPOSITIONS FOR THE MANAGEMENT OF PREMENSTRUAL SYNDROME AND ALLEVIATION OF MENOPAUSAL DISORDERS
PHARMACEUTICAL COMPOSITIONS FOR THE NASAL DELIVERY OF COMPOUNDS USEFUL FOR THE TREATMENT OF OSTEOPOROSIS
PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT A GASTROINTESTINAL DISEASES
PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF INSOLUBLE ACTIVE PRINCIPLES
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CUTANEOUS AND ORAL MUCOUS MEMBRANE INFLAMMATIONS
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES COMPRISING THE B-OLIGOMER OF PERTUSSIS TOXIN OR ITS SUBUNITS
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCERS SUSCEPTIBLE TO TREATMENT WITH THE COPPER COMPLEX OF S-(METHYLTHIO)-DL-HOMOCYSTEINE OR THE L-ENANTIMORPH THEREOF
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH DECREASED BLOOD FLOW
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DEPRESSIVE DISORDERS
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETIC MALE SEXUAL DYSFUNCTION
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF THE RESPIRATORY TRACT
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEREDITARY TYOSINEMIA TYPE I
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PSORIASIS
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISORDERS
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION OR AUTOIMMUNE OR INFLAMMATORY CONDITIONS COMPRISING CYCLOSPORIN A AND 40-0-(2-HYDROXYETHYL)-RAPAMYCIN
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TRANSPLANT REJECTION, AUTOIMMUNE OR INFLAMMATORY CONDITIONS COMPRISING CYCLOSPORIN A AND 40-O-(2-HYDROXYETHYL)-RAPAMYCIN
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF DISORDERS IN THE EYE
PHARMACEUTICAL COMPOSITIONS FOR TOPICAL APPLICATION
PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING (S)-2-(4-ISOBUTYLPHENYL) PROPINONIC ACID
PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING HYALURONIC ACID AND ITS DERIVATIVES
PHARMACEUTICAL COMPOSITIONS FOR TRANSMUCOSAL DELIVERY OF PEPTIDES
PHARMACEUTICAL COMPOSITIONS FOR TREATING ADRENOLEUKODYSTROPHY
PHARMACEUTICAL COMPOSITIONS FOR TREATING AND/OR PREVENTING CNS DISORDERS
PHARMACEUTICAL COMPOSITIONS FOR TREATING BONE DISORDERS
PHARMACEUTICAL COMPOSITIONS FOR TREATING CERTAIN CANCERS
PHARMACEUTICAL COMPOSITIONS FOR TREATING GASTROINTESTINAL DISTRESS
PHARMACEUTICAL COMPOSITIONS FOR TREATING LATE PHASE ALLERGIC REACTIONS AND INFLAMMATORY DISEASES
PHARMACEUTICAL COMPOSITIONS FOR TREATING PRIAPISM AND PEYRONIE'S SYNDROME
PHARMACEUTICAL COMPOSITIONS FOR TREATING PSORIASIS
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CIRCULATORY DISORDERS USING N-SUBSTITUTED (.ALPHA.-IMIDAZOLYL-TOLUYL) PYRROLE ANIOTENSIN II ANTAGONISTS
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DEPRESSION AND LOW BLOOD PRESSURE
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF EGF RECEPTOR ASSOCIATED CANCERS
PHARMACEUTICAL COMPOSITIONS FOR ULCER
PHARMACEUTICAL COMPOSITIONS FOR USE IN TREATING INFLAMMATION
PHARMACEUTICAL COMPOSITIONS HAVING ACTIVITY ON THE CUTANEOUS MICROCIRCULATION
PHARMACEUTICAL COMPOSITIONS HAVING ANTIVIRAL ACTIVITY AGAINST HUMAN CYTOMEGALOVIRUS
PHARMACEUTICAL COMPOSITIONS HAVING APPETITE SUPPRESSANT ACTIVITY
PHARMACEUTICAL COMPOSITIONS HAVING DEPRESSED MELTING POINTS
PHARMACEUTICAL COMPOSITIONS HAVING GOOD DISSOLUTION PROPERTIES
PHARMACEUTICAL COMPOSITIONS HAVING IMPROVED DISSOLUTION PROPERTIES
PHARMACEUTICAL COMPOSITIONS HAVING STEROID NITRATE ESTER DERIVATIVES USEFUL AS ANTI-INFLAMMATORY DRUGS
PHARMACEUTICAL COMPOSITIONS HAVING THERAPEUTICAL ACTIVITY BASED ON MERCAPTOETHANSULPHONIC ARGININE SALT
PHARMACEUTICAL COMPOSITIONS IN FORM OF POLYMERIC MICROPARTICLES OBTAINED BY EXTRUSION AND SPHERONIZATION
PHARMACEUTICAL COMPOSITIONS IN SEMISOLID FORM AND A DEVICE FOR ADMINISTRATION THEREOF
PHARMACEUTICAL COMPOSITIONS IN THE FORM OF PARTICLES SUITABLE FOR THE CONTROLLED RELEASE OF PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PROCESS FOR PREPARING THE SAME COMPOSITIONS
PHARMACEUTICAL COMPOSITIONS IN THE FORM OF STABLE SUCRALFATE SUSPENSIONS FREE OF SUSPENDING AGENTS
PHARMACEUTICAL COMPOSITIONS IN THE FORM OF SUSTAINED-RELEASE TABLETS BASED ON HIGH MOLECULAR WEIGHT POLYSACCHARIDE GRANULES
PHARMACEUTICAL COMPOSITIONS INCLUDING A DRUG, A CROSS-LINKED POLYMERIC SUBSTANCE, AN OIL, AND A SURFACE ACTIVE AGENT
PHARMACEUTICAL COMPOSITIONS INCLUDING MIXTURES OF AN ADENOSINE COMPOUND AND A CATECHOLAMINE
PHARMACEUTICAL COMPOSITIONS INCORPORATING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS
PHARMACEUTICAL COMPOSITIONS METHODS AND KITS FOR TREATMENT AND DIAGNOSIS OF BREAST CANCER
PHARMACEUTICAL COMPOSITIONS OF 5-ALKYNYL URACIL COMPOUNDS
PHARMACEUTICAL COMPOSITIONS OF 5-ALKYNYL-DIDEOXYRIBOURACIL
PHARMACEUTICAL COMPOSITIONS OF 5-SUBSTITUTED URACIL COMPOUNDS
PHARMACEUTICAL COMPOSITIONS OF ACETAMIDOBENZAMIDE COMPOUNDS FOR NEURODEGENERATIVE DISORDERS
PHARMACEUTICAL COMPOSITIONS OF ALKYLSULPHONAMIDES 5HT1 AGONISTS FOR RECTAL ADMINISTRATION
PHARMACEUTICAL COMPOSITIONS OF AMETHOCAINE FREE BASE
PHARMACEUTICAL COMPOSITIONS OF ARGLABIN AND ARGLABIN DERIVATIVES
PHARMACEUTICAL COMPOSITIONS OF BACTERICIDAL/PERMEABILITY INCREASING PROTEIN (BPI)
PHARMACEUTICAL COMPOSITIONS OF BOTULINUM TOXIN OR BOTULINUM NEUROTOXIN AND METHODS OF PREPARATION
PHARMACEUTICAL COMPOSITIONS OF CALCITONIN DRUG-OLIGOMER CONJUGATES AND METHODS OF TREATING DISEASES THEREWITH
PHARMACEUTICAL COMPOSITIONS OF CHITOSAN WITH TYPE-A GELATIN
PHARMACEUTICAL COMPOSITIONS OF CHONDROITINASE ABC ISOLATED FROM PROTEUS VULGARIS ATCC 6896
PHARMACEUTICAL COMPOSITIONS OF CIMETIDINE
PHARMACEUTICAL COMPOSITIONS OF CONJUGATED ESTROGENS AND METHODS FOR THEIR USE
PHARMACEUTICAL COMPOSITIONS OF ERYTHROPOIETIN
PHARMACEUTICAL COMPOSITIONS OF FIBRINOLYTIC AGENT
PHARMACEUTICAL COMPOSITIONS OF GALLIUM COMPLEXES OF 3-HYDROXY-4-PYRONES
PHARMACEUTICAL COMPOSITIONS OF INDAZOLES AND METHODS OF USE THEREOF
PHARMACEUTICAL COMPOSITIONS OF LEVO-ENANTIOMERS OF MEDETOMIDINE DERIVATIVES AND THEIR USE
PHARMACEUTICAL COMPOSITIONS OF LIPOPOLYSACCHARIDE-BINDING POLYPEPTIDES
PHARMACEUTICAL COMPOSITIONS OF MELOXICAM WITH IMPROVED SOLUBILITY AND BIOAVAILABILITY
PHARMACEUTICAL COMPOSITIONS OF NITRO- AND AMINOBENZAMIDE COMPOUNDS FOR NEURODEGENERATIVE DISORDERS
PHARMACEUTICAL COMPOSITIONS OF O-DESMETHYL-N-MONO-DESMETHYL-TRAMADOL
PHARMACEUTICAL COMPOSITIONS OF PEPTIDES HAVING LOW SOLUBILITY IN PHYSIOLOGICAL MEDIUM
PHARMACEUTICAL COMPOSITIONS OF PROPOFOL AND EDETATE
PHARMACEUTICAL COMPOSITIONS OF TEBUFELONE
PHARMACEUTICAL COMPOSITIONS OF THE R-ENANTIOMER OF N-PROPARGYL -1-AMINOINDAN
PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITAZOXANIDE
PHARMACEUTICAL COMPOSITIONS OF URIDINE TRIPHOSPHATE
PHARMACEUTICAL COMPOSITIONS OF VANADIUM BIGUANIDE COMPLEXES AND THEIR USE
PHARMACEUTICAL COMPOSITIONS SUITABLE FOR USE AGAINST HISTOMONIASIS
PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING SAME
PHARMACEUTICAL COMPOSITIONS TO TETRAC AND METHODS OF USE THEREOF
PHARMACEUTICAL COMPOSITIONS USING THIAZEPINE
PHARMACEUTICAL COMPOSITIONS WITH ANALGESICS CONTAINING CODEINE
PHARMACEUTICAL COMPOSITIONS WITH ANIT-CANCER ACTIVITY AND METHOD FOR THE TREATMENT OF CANCER
PHARMACEUTICAL COMPOSITIONS WITH ANTI-CANCER ACTIVITY AGAINST CARCINOMA AND METHOD FOR THE TREATMENT OF CARCINOMA
PHARMACEUTICAL COMPOSITIONS WITH ANTIMICROBIAL ACTIVITY
PHARMACEUTICAL COMPOSITIONS WITH ANTITUMOUR ACTIVITY
PHARMACEUTICAL COMPOSITIONS WITH CONSTANT EROSION VOLUME FOR ZERO ORDER CONTROLLED RELEASE
PHARMACEUTICAL COMPOSITIONS, 2-BENZOTHIAZOLAMINE DERIVATIVES, AND THEIR PREPARATION
PHARMACEUTICAL COMPOSITIONS, CONTAINING S-ADENOSYL-L-METHIONINE SALT, 5-METHYL-TETRAHYDROFOLIC ACID AND 5-FORMYLTETRAHYDROFOLIC ACID
PHARMACEUTICAL COMPOSITIONS, DOSAGE FORMS AND METHODS FOR ORAL ADMINISTRATION OF EPOTHILONES
PHARMACEUTICAL COMPOSITIONS, MAINLY VAGINAL SUPPOSITORY, CONTAINING MANY DIFFERENT ACTIVE INGREDIENTS
PHARMACEUTICAL COMPOSITIONS, METHODS, AND KITS FOR TREATMENT AND DIAGNOSIS OF LUNG CANCER
PHARMACEUTICAL COMPOSITIONS, NOVEL USES, AND NOVEL FORM OF .ALPHA.-TOCOPHERYLPHOSPHOCHOLINE
PHARMACEUTICAL COMPOSITIONS, NOVEL USES, AND NOVEL FORM OF TOCOPHERYLPHOSPHOCHOLINE
PHARMACEUTICAL COMPOUND COMPRISING A PYRAZOLE DERIVATIVE AND METHODS OF USING THE SAME FOR THE TREATMENT OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL ASSOCIATED DISEASES
PHARMACEUTICAL COMPOUNDS
PHARMACEUTICAL COMPOUNDS COMPRISING POLYAMINES SUBSTITUTED WITH ELECTRON-AFFINIC GROUPS
PHARMACEUTICAL COMPOUNDS COMPRISING POLYAMINES SUBSTITUTED WITH ELECTRON-AFFINIC GROUPS AND METHOD OF APPLICATION THEREOF
PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF CNS DISEASES
PHARMACEUTICAL COMPSITION OF HERPES SIMPLEX VIRUS TYPE-1 (HSV-1), GLYCOPROTEINS
PHARMACEUTICAL CONTAINER
PHARMACEUTICAL CONTAINER AND INHALER DEVICE
PHARMACEUTICAL CONTAINER WITH METAL CLOSURES HAVING REDUCED PARTICULATES
PHARMACEUTICAL CONTAINING N-METHYLATED CYCLIC UNDECAPEPTIDES
PHARMACEUTICAL CONTAINING TISSUE PROTEIN PP4, A PROCESS FOR THE PREPARATION OF PP4 AND FOR THE PASTEURIZATION THEREOF, AND THE USE OF PP4
PHARMACEUTICAL CONTAINING TNF INHIBITOR
PHARMACEUTICAL CONTAINMENT PACKAGE
PHARMACEUTICAL CONTROL OF INFLAMMATION
PHARMACEUTICAL CONTROLLED RELEASE TABLETS CONTAINING A CARRIER MADE OF CROSS-LINKED AMYLOSE AND HYDROXYPROPYLMETHYLCELLULOSE
PHARMACEUTICAL CONTROLLED-RELEASE COMPOSITION WITH BIOADHESIVE PROPERTIES
PHARMACEUTICAL CYCLOSPORIN FORMULATION WITH IMPROVED BIOPHARMACEUTICAL PROPERTIES, IMPROVED PHYSICAL QUALITY AND GREATER STABILITY, AND METHOD FOR PRODUCING SAID FORMULATION
PHARMACEUTICAL DELIVERY DEVICE AND METHOD OF PREPARATION THEREFOR
PHARMACEUTICAL DENTAL FORMULATION FOR TOPICAL APPLICATION OF METRONIDAZOLE BENZOATE AND CHLORHEXIDINE GLUCONATE
PHARMACEUTICAL DENTAL FORMULATION FOR TOPICAL APPLICATION OF METRONIDAZOLE BENZOATE, CHLORHEXIDINE GLUCONATE AND LOCAL ANESTHETIC
PHARMACEUTICAL DEPOT COMPOSITIONS CONTAINING HIRUDIN
PHARMACEUTICAL DIKETOPIPERAZINE COMPOUNDS
PHARMACEUTICAL DIPEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF
PHARMACEUTICAL DIPEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF: IMMUNODEPRESSANTS
PHARMACEUTICAL DIPEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF: IMMUNOSTIMULANTS
PHARMACEUTICAL DIPEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF: SYSTEMIC TOXICITY
PHARMACEUTICAL DISPENSER FOR DISPENSING A VARIABLE AND PREDETERMINED NUMBER OF TABLETS OR SIMILAR PRODUCTS PACKAGED IN A BLISTER BAND
PHARMACEUTICAL DISPENSING APPARATUS AND METHOD
PHARMACEUTICAL DISPENSING ARRANGEMENT
PHARMACEUTICAL DISPENSING DEVICE AND METHODS
PHARMACEUTICAL DISPENSING SYSTEM
PHARMACEUTICAL DOPAMINE GLYCOCONJUGATE COMPOSITIONS AND METHODS OF THEIR PREPARATION
PHARMACEUTICAL DOSAGE FORM FOR COLONIC DELIVERY
PHARMACEUTICAL DOSAGE FORM FOR OCULAR ADMINISTRATION AND PREPARATION PROCESS
PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF HYDROPHILIC DRUGS, PARTICULARLY LOW MOLECULAR WEIGHT HEPARIN
PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF D-THREO-METHYLPHENIDATE AND A SECOND CNS STIMULANT
PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF METHYLPHENIDATE
PHARMACEUTICAL DOSAGE FORM FOR THE MEDICATION OF FISH
PHARMACEUTICAL DOSAGE FORM FOR TRANSDERMAL ADMINISTRATION
PHARMACEUTICAL DOSAGE FORM FOR TREATMENT OF MULTIPLE SCLEROSIS
PHARMACEUTICAL DOSAGE FORM WITH MULTIPLE ENTERIC POLYMER COATINGS FOR COLONIC DELIVERY
PHARMACEUTICAL DOSAGE FORMS
PHARMACEUTICAL DOSAGE FORMULATIONS OF FENOFIBRATE AND THEIR APPLICATIONS
PHARMACEUTICAL DOSAGE UNIT FOR RECTAL ADMINISTRATION
PHARMACEUTICAL DOSAGE UNIT FOR TREATING INFLAMMATION COMPRISING PROTEASE NEXIN-I
PHARMACEUTICAL DOSING DISPENSER
PHARMACEUTICAL DRUG DOSAGE FORMS PROVIDING DIFFERENT RELEASE RATES
PHARMACEUTICAL EMULSION
PHARMACEUTICAL ENEMA PREPARATION
PHARMACEUTICAL EPINEPHRINE-PILOCARPINE COMPOUNDS AND PROCESS OF PREPARATION THEREOF
PHARMACEUTICAL EXCIPIENT HAVING IMPROVED COMPRESSABILITY
PHARMACEUTICAL EXCIPIENT HAVING IMPROVED COMPRESSIBILITY
PHARMACEUTICAL FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION CONTAINING POLYPEPTIDES
PHARMACEUTICAL FOR THE THERAPY OF IMMUNE DEFICIENCY CONDITIONS
PHARMACEUTICAL FOR THE TREATMENT OF SKIN DISORDERS
PHARMACEUTICAL FOR TREATING OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS
PHARMACEUTICAL FOR TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS
PHARMACEUTICAL FORM FOR DELIVERY OF ACTIVE SUBSTANCES TO WOUNDS
PHARMACEUTICAL FORMS FOR THE ORAL ADMINISTRATION OF MESNA
PHARMACEUTICAL FORMULATION
PHARMACEUTICAL FORMULATION AND ITS USE
PHARMACEUTICAL FORMULATION AND PROCESS
PHARMACEUTICAL FORMULATION COMPRISED OF POLYMYXINTRIMETHOPRIM AND AN ANTI-INFLAMMATORY DRUG FOR OPHTHALMIC AND OTIC TOPICAL USE
PHARMACEUTICAL FORMULATION COMPRISING A 2- [(2-PYRIDINYL) METHYL] SULFINYL BENZIMIDAZOLE HAVING ANTI-ULCER ACTIVITY AND A PROCESS FOR THE PREPARATION OF SUCH FORMULATION
PHARMACEUTICAL FORMULATION COMPRISING A 2-AMINOACETAMIDE DERIVATIVE AND AN ION EXCHANGE RESIN
PHARMACEUTICAL FORMULATION COMPRISING OMEPRAZOLE
PHARMACEUTICAL FORMULATION CONTAINING A DNA-SODIUM SALT FOR BURN AND WOUND TREATMENT
PHARMACEUTICAL FORMULATION CONTAINING A HYDROPHOBIC ACTIVE SUBSTANCE AND AN EFFERVESCENT SYSTEM
PHARMACEUTICAL FORMULATION CONTAINING DFMO FOR THE TREATMENT OF CANCER
PHARMACEUTICAL FORMULATION CONTAINING HEPARIN AND ENDO-BETA-GLUCURONIDASE, USEFUL FOR THE TREATMENT OF THROMBOSIS
PHARMACEUTICAL FORMULATION FOR ACID-LABILE COMPOUNDS
PHARMACEUTICAL FORMULATION FOR NASAL ADMINISTRATION
PHARMACEUTICAL FORMULATION FOR POORLY WATER SOLUBLE CAMPTOTHECIN ANALOGUES
PHARMACEUTICAL FORMULATION FOR SUBCUTANEOUS INTRAMUSCULAR OR INTRADERMAL ADMINISTRATION OF FACTOR VIII
PHARMACEUTICAL FORMULATION FOR THE PROPHYLAXIS AND PRETREATMENT OF A POISONING CAUSED BY ORGANOPHOSPHORUS CHOLINESTERASE INHIBITORS
PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF DIABETES MELLITUS
PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF NICOTINE DEPENDENCE
PHARMACEUTICAL FORMULATION FOR TREATING LIVER DISORDERS
PHARMACEUTICAL FORMULATION HAVING ENHANCED BILE ACID BINDING AFFINITY
PHARMACEUTICAL FORMULATION IN THE FORM OF AN EFFERVESCENT AND/OR DISINTEGRATING TABLET OR OF INSTANT GRANULATE, AND PROCESS FOR THEIR PREPARATION
PHARMACEUTICAL FORMULATION IN THE FORM OF AQUEOUS SUSPENSION
PHARMACEUTICAL FORMULATION OF FLUTICASONE PROPIONATE
PHARMACEUTICAL FORMULATION OF HUMAN-GROWTH HORMONE PRETREATED WITH ZINC SALT
PHARMACEUTICAL FORMULATION OF OMEPRAZOLE
PHARMACEUTICAL FORMULATION USEFUL FOR THE TREATMENT OF HEPATITIS B, HEPATITIS C AND OTHER VIRAL INFECTIONS OF THE LIVER AND A PROCESS FOR ITS PREPARATION
PHARMACEUTICAL FORMULATION WHICH DOES NOT INDUCE TOLERANCE
PHARMACEUTICAL FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCES
PHARMACEUTICAL FORMULATION WITH EFFERVESCENT COUPLE
PHARMACEUTICAL FORMULATIONS
PHARMACEUTICAL FORMULATIONS AND APPLICATIONS THEREOF FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME
PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING PATIENTS SUFFERING FROM DISEASES THAT CAUSE MUSCULAR HYPOTONIA
PHARMACEUTICAL FORMULATIONS AND PROCESS FOR THEIR PREPARATION
PHARMACEUTICAL FORMULATIONS BASED ON A KETOPROFEN SOLUTION IN SOFT CAPSULES, AND PROCESSES FOR THEIR PREPARATION
PHARMACEUTICAL FORMULATIONS COMPRISED OF AMOXICILLIN IN COMBINATION WITH CLAVULANIC ACID
PHARMACEUTICAL FORMULATIONS COMPRISED OF COMPACTED AMOXICILLIN GRANULATES
PHARMACEUTICAL FORMULATIONS COMPRISING A CLAVULANIC ACID SALT AND ERITHROMYCIN DERIVATITE
PHARMACEUTICAL FORMULATIONS COMPRISING AMINOALKYL PHOSPHOROTHIOATES
PHARMACEUTICAL FORMULATIONS COMPRISING LABDANES FOR THE TREATMENT OF TUMORS OR LEUKEMIAS
PHARMACEUTICAL FORMULATIONS COMPRISING LEVORMELOXIFENE COMPOUNDS
PHARMACEUTICAL FORMULATIONS COMPRISING MICROCAPSULES
PHARMACEUTICAL FORMULATIONS COMPRISING POLYTHIOUREA AND METHODS OF USE THEREOF
PHARMACEUTICAL FORMULATIONS COMPRISING VEGETAL MATERIAL SELECTED FROM TRICHILIA
PHARMACEUTICAL FORMULATIONS CONTAINING A .BETA.-LACTAMASE INHIBITING PENEM IN COMBINATION WITH .BETA.-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
PHARMACEUTICAL FORMULATIONS CONTAINING A COMBINATION OF CARBIDOPA AND LEVIDOPA
PHARMACEUTICAL FORMULATIONS CONTAINING A NON-STEROIDAL ANTIINFLAMMATORY DRUG AND A PROTON PUMP INHIBITOR
PHARMACEUTICAL FORMULATIONS CONTAINING A PHARMACOLOGICALLY ACTIVE IONIZABLE SUBSTANCE AS WELL AS A PROCESS FOR THE PREPARATION THEREOF
PHARMACEUTICAL FORMULATIONS CONTAINING A PHARMACOLOGICALLY ACTIVE IONIZABLE SUBSTANCE AS WELL AS PROCESS FOR THE PREPARATION THEREOF
PHARMACEUTICAL FORMULATIONS CONTAINING ACRIVASTINE
PHARMACEUTICAL FORMULATIONS CONTAINING DARIFENACIN
PHARMACEUTICAL FORMULATIONS CONTAINING POORLY SOLUBLE DRUG SUBSTANCES
PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE
PHARMACEUTICAL FORMULATIONS CONTAINING ZOLMITRIPTAN
PHARMACEUTICAL FORMULATIONS EMPLOYING ESTERIFIED ALKOXYLATED POLYOLS AS VEHICLES
PHARMACEUTICAL FORMULATIONS FOR ACID LABILE SUBSTANCES
PHARMACEUTICAL FORMULATIONS FOR AEROSOLS WITH TWO OR MORE ACTIVE SUBSTANCES
PHARMACEUTICAL FORMULATIONS FOR IGF/IGFBP
PHARMACEUTICAL FORMULATIONS FOR PREVENTING DRUG TOLERANCE
PHARMACEUTICAL FORMULATIONS FOR SUSTAINED DRUG DELIVERY
PHARMACEUTICAL FORMULATIONS HAVING IMPROVED DISINTEGRATION AND/OR ABSORPTIVITY
PHARMACEUTICAL FORMULATIONS IN DRY FORM FOR THE ORAL ADMINISTRATION OF A CYCLIC QUATERNARY AMMONIUM COMPOUND
PHARMACEUTICAL FORMULATIONS IN FORM OF THIXOTROPIC GEL
PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPYLMETHYLCELLULOSE CAPSULES
PHARMACEUTICAL FORMULATIONS OF CEFACLOR
PHARMACEUTICAL FORMULATIONS OF CIPROFLOXACIN
PHARMACEUTICAL FORMULATIONS OF COMPACTED GRANULATES OF .BETA.-LACTAM ANTIBIOTICS
PHARMACEUTICAL FORMULATIONS OF CORTICOTROPIN RELEASING FACTOR HAVING IMPROVED STABILITY IN LIQUID FORM
PHARMACEUTICAL FORMULATIONS OF CYCLIC UREA TYPE COMPOUNDS
PHARMACEUTICAL FORMULATIONS OF HIGHLY LIPOPHILIC CAMPTOTHECIN DERIVATIVES
PHARMACEUTICAL FORMULATIONS OF NERVE GROWTH FACTOR
PHARMACEUTICAL FORMULATIONS OF OSTEOGENIC PROTEINS
PHARMACEUTICAL FORMULATIONS OF POORLY WATER SOLUBLE CAMPTOTHECIN ANALOGUES AND NMP
PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHODS OF USE THEREOF
PHARMACEUTICAL FORMULATIONS OF SPIRAMYCIN
PHARMACEUTICAL FORMULATIONS OF TAXANES
PHARMACEUTICAL FORMULATIONS THAT HAVE A BIOLOGICALLY ACTIVE HYDROPHILIC PHASE AND A CHYLOMICRA-CONTAINING HYDROPHOBIC PHASE
PHARMACEUTICAL GEL AND AEROSOL FORMULATIONS AND METHODS TO ADMINISTER THE SAME TO SKIN AND MUCOSAL SURFACES
PHARMACEUTICAL GEL PREPARATION APPLICABLE TO MUCOSAL SURFACES AND BODY TISSUES
PHARMACEUTICAL GRADE BOTANICAL DRUGS
PHARMACEUTICAL GRADE SAW PALMETTO
PHARMACEUTICAL GRADE ST. JOHN'S WORT
PHARMACEUTICAL GRANULATE
PHARMACEUTICAL GRANULATED COMPOSITION AND METHOD FOR PREPARING SAME
PHARMACEUTICAL GRINDING APPARATUS AND METHOD FOR USING SAME
PHARMACEUTICAL GROWTH HORMONE FORMULATIONS
PHARMACEUTICAL HYDROGEL FORMULATIONS, AND ASSOCIATED DRUG DELIVERY DEVICES AND METHODS
PHARMACEUTICAL HYDROPHILIC SPRAY CONTAINING NITROGLYCERIN FOR TREATING ANGINA
PHARMACEUTICAL INHALATION COMPOSITIONS
PHARMACEUTICAL INJECTION SOLUTION CONTAINING TAXOL
PHARMACEUTICAL INSULIN-POTENTIATING CR(III) COMPLEXES WITH GTF-LIKE ACTIVITY
PHARMACEUTICAL IODINE COMPOSITIONS WITH REDUCED IRRITANCY
PHARMACEUTICAL ION EXCHANGE RESIN COMPOSITION
PHARMACEUTICAL KIT
PHARMACEUTICAL KIT COMPRISING MIDODRINE AS ACTIVE DRUG SUBSTANCE
PHARMACEUTICAL KIT FOR OXYGEN-SENSITIVE DRUGS
PHARMACEUTICAL LACTAM COMPOSITIONS FOR INHIBITION OF ERYTHROCYTE AND THROMBOCYTE AGGREGATION
PHARMACEUTICAL LEVOTHYROXINE PREPARATION
PHARMACEUTICAL LIQUID COMPOSITION CONTAINING BEZOAR BOVIS
PHARMACEUTICAL LIQUID COMPOSITION CONTAINING BEZOAR BOVIS AND PREPARATION FOR ITS MANUFACTURE
PHARMACEUTICAL LOZENGES
PHARMACEUTICAL LYSINE-CONTAINING POLYPEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF
PHARMACEUTICAL MARKETING DEVICE AND METHOD OF USE
PHARMACEUTICAL MARKETING DEVICE AND SYSTEM
PHARMACEUTICAL MATRIX PELLETS, TABLETS AND COMPOSITION FOR THE PREPARATION THEREOF
PHARMACEUTICAL METHOD FOR THE TREATMENT OF SEVERE BLOOD LOSS AND FOR THE INHIBITION OR TREATMENT OF HEMORRHAGIC SHOCK
PHARMACEUTICAL METHOD OF TREATMENT USING PYRAZOLOPYRIDINE COMPOUND
PHARMACEUTICAL METHOD USING 6-SUBSTITUTED-1, 2, 3, 4-TETRAHYDRO-9H-CARBAZOLES AND 7-SUBSTITUTED-10H -CYCLOHEPTA (7, 6-B) INDOLES
PHARMACEUTICAL METHODS FOR RELIEF OF DYSMENORRHEA AND/OR PREMENSTRUAL SYNDROME AND PROCESS
PHARMACEUTICAL METHODS OF DELIVERING FOLIC ACID
PHARMACEUTICAL METHODS OF TREATMENT WITH ACAT INHIBITORS AND HMG-COA REDUCTASE INHIBITORS
PHARMACEUTICAL METHODS OF USE OF 5-SUBSTITUTED AND 5,5 DISUBSTITUTED-3,4-DIHYDROXY-2(5H)-FURANONES
PHARMACEUTICAL METHODS OF USING HETEROCYCLIC DERIVATIVES OF N-PHENYLAMIDES
PHARMACEUTICAL MICROENCAPSULATION
PHARMACEUTICAL MIXING CONTAINER WITH BUOYANT MIXING ELEMENT
PHARMACEUTICAL MIXING CONTAINER WITH COMBINATION STOPPER AND PUMP
PHARMACEUTICAL MIXING CONTAINER WITH EXTENDABLE AGITATOR BELLOWS
PHARMACEUTICAL MIXING CONTAINER WITH ROTATABLE VANED INTERNAL MAGNETIC MIXING ELEMENT
PHARMACEUTICAL MIXING CONTAINER WITH ROTATIONALLY MOUNTED HOUSING
PHARMACEUTICAL MIXTURE COMPRISING A COMBINATION OF A PROFEN AND OTHER ACTIVE COMPOUNDS
PHARMACEUTICAL MIXTURE COMPRISING A PROFEN
PHARMACEUTICAL MOXIFLOXACIN PREPARATION
PHARMACEUTICAL MULTIPARTICULATES
PHARMACEUTICAL MULTIPLE UNIT PARTICULATE FORMULATION IN THE FORM OF COATED CORES
PHARMACEUTICAL NANOSUSPENSIONS FOR MEDICAMENT ADMINISTRATION AS SYSTEMS WITH INCREASED SATURATION SOLUBILITY AND RATE OF SOLUTION
PHARMACEUTICAL NON INORGANIC SALINE SOLUTIONS FOR ENDONASAL ADMINISTRATION OF A CALCITONIN
PHARMACEUTICAL OINTMENT BEING FREE FROM SKIN IRRITATIVE ACTION AND A PROCESS FOR THE PREPARATION THEREOF
PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING A COMBINATION OF A RETINOID AND A STEROL
PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING HYDROQUINONE AND KOJIC ACID
PHARMACEUTICAL OR DIETETIC COMPOSITION
PHARMACEUTICAL OR DIETETIC MUSHROOM-BASED COMPOSITIONS
PHARMACEUTICAL OR DIETETIC PREPARATION FOR IMPROVEMENT OF FERTILITY AND SPERM QUALITY
PHARMACEUTICAL OR FOOD COMPOSITION FOR TREATING PATHOLOGIES ASSOCIATED WITH GRAFT REJECTION OR AN ALLERGIC OR AUTOIMMUNE REACTION
PHARMACEUTICAL OR FOOD COMPOSITION FOR TREATING PATHOLOGIES RELATED TO GRAFT VERSUS HOST, ALLERGIC OR AUTOIMMUNE REACTION
PHARMACEUTICAL OR VETERINARY COMPOSITION
PHARMACEUTICAL ORAL CONTROLLED RELEASE COMPOSITION COMPRISING SMALL PELLETS OF BILE ACIDS
PHARMACEUTICAL ORAL PATCH FOR CONTROLLED RELEASE OF PHARMACEUTICAL AGENTS IN THE ORAL CAVITY
PHARMACEUTICAL ORAL PREPARATION OF A COMPOUND HAVING AN ANTIFUNGIC ACTIVITY, AND PREPARATION METHOD
PHARMACEUTICAL PACKAGING SYSTEM
PHARMACEUTICAL PACKAGING WITH CAPSULE SEALING MEANS
PHARMACEUTICAL PACKAGING WITH SEPARATION MEANS
PHARMACEUTICAL PACKING DEVICE COMPRISING A HOLLOW PLASTIC BODY HAVING AN IMPROVED INTERNAL LUBRICANT LAYER AND METHOD OF MAKING SAME
PHARMACEUTICAL PELLET FORMULATION
PHARMACEUTICAL PILL RECOGNITION AND VERIFICATION SYSTEM
PHARMACEUTICAL PIPERAZINE COMPOUNDS
PHARMACEUTICAL PLASTERS
PHARMACEUTICAL POWDER CARTRIDGE WITH INTEGRATED METERING DEVICE AND INHALER FOR POWDERED MEDICAMENTS
PHARMACEUTICAL PREPARATION
PHARMACEUTICAL PREPARATION ADHERING TO THE SKIN, IN PARTICULAR A TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-.BETA.-ESTRADIOL TO THE HUMAN ORGANISM
PHARMACEUTICAL PREPARATION ADMINISTRATOR
PHARMACEUTICAL PREPARATION AND A METHOD FOR THE TREATMENT OF DIABETES
PHARMACEUTICAL PREPARATION AND METHOD FOR TREATMENT AND PREVENTION OF FIBROMYALGIA AND CHRONIC FATIGUE
PHARMACEUTICAL PREPARATION AND METHOD FOR TREATMENT OF DIABETES
PHARMACEUTICAL PREPARATION AND METHOD OF TREATMENT FOR LIVER DYSFUNCTION
PHARMACEUTICAL PREPARATION AND PROCESS FOR ITS MANUFACTURE
PHARMACEUTICAL PREPARATION APPLICABLE TO MUCOSAL SURFACES AND BODY TISSUES
PHARMACEUTICAL PREPARATION BASED ON FETAL SUSPENSION AND METHODS OF TREATING ACQUIRED IMMUNE DEFICIENCY SYNDROME (HIV INJECTION)
PHARMACEUTICAL PREPARATION BASED ON LYS-PLASMINOGEN
PHARMACEUTICAL PREPARATION BASED ON RHAMNOLIPID
PHARMACEUTICAL PREPARATION BINDING WITH GASTRIC ACID
PHARMACEUTICAL PREPARATION COMPRISING AN ACYLCARNITINE
PHARMACEUTICAL PREPARATION COMPRISING EICOSAPENTAENOIC ACID AND/OR STEARIDONIC ACID
PHARMACEUTICAL PREPARATION COMPRISING FAT EMULSION OF FAT MICROPARTICLES
PHARMACEUTICAL PREPARATION COMPRISING LYOPHILIZED LIPOSOMES ENCAPSULATING AN ACTIVE PRINCIPLE WHICH IS HIGHLY INSOLUBLE IN WATER, AND THE PROCESS FOR PREPARING THE SAID PREPARATION
PHARMACEUTICAL PREPARATION CONTAINING A CYCLOPEPTIDE AND A CHEMOTHERAPEUTIC AGENT OR AN ANGIOGENESIS INHIBITOR
PHARMACEUTICAL PREPARATION CONTAINING A SPECIFIC CRYSTAL MODIFICATION OF ISOPROPYL-(2-METHOXYETHYL) 1,4-DIHYDRO-2, 6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE
PHARMACEUTICAL PREPARATION CONTAINING CYCLOSPORIN(S) FOR ORAL ADMINISTRATION AND PROCESS FOR PRODUCING SAME
PHARMACEUTICAL PREPARATION CONTAINING CYCLOSPORIN(S) FOR ORAL ADMINISTRATION AND PROCESS FOR PRODUCING THE SAID PREPARATION
PHARMACEUTICAL PREPARATION CONTAINING CYCLOSPORINE(S) FOR INTRAVENOUS ADMINISTRATION AND A PROCESS FOR ITS PRODUCTION
PHARMACEUTICAL PREPARATION CONTAINING CYCLOSPORINE(S) FOR INTRAVENOUS ADMINISTRATION AND PROCESS FOR ITS PRODUCTION
PHARMACEUTICAL PREPARATION CONTAINING DITHRANOL
PHARMACEUTICAL PREPARATION CONTAINING HUMAN GROWTH HORMONE
PHARMACEUTICAL PREPARATION CONTAINING L-ASPARTATE OR L-ASPARAGINE FOR PREVENTING ETHANOL TOXICITY, AND PROCESS FOR PREPARATION THEREOF
PHARMACEUTICAL PREPARATION CONTAINING METFORMIN AND A PROCESS FOR PRODUCING IT
PHARMACEUTICAL PREPARATION CONTAINING NIMESULIDE FOR ORAL ADMINISTRATION
PHARMACEUTICAL PREPARATION CONTAINING NIMESULIDE FOR TOPICAL USE
PHARMACEUTICAL PREPARATION CONTAINING PLASMINOGEN ACTIVATORS
PHARMACEUTICAL PREPARATION CONTAINING PROSTAGLANDIN COMPOUND FOR RECTAL OR VAGINAL ADMINISTRATION
PHARMACEUTICAL PREPARATION CONTAINING PROTEIN C AND A THROMBOLYTICALLY ACTIVE SUBSTANCE
PHARMACEUTICAL PREPARATION CONTAINING VASOACTIVE INTESTINAL POLYPEPTIDE OR ITS ANALOGUE
PHARMACEUTICAL PREPARATION CONTROLLED TO RELEASE MEDICINAL ACTIVE INGREDIENT AT TARGETED SITE IN INTESTINAL TRACT
PHARMACEUTICAL PREPARATION FOR ADMINISTRATION BY PERCUTANEOUS ABSORPTION AND A METHOD FOR THEIR MANUFACTURE
PHARMACEUTICAL PREPARATION FOR CONTROLLING PATHOGENIC INTESTINAL BACTERIA
PHARMACEUTICAL PREPARATION FOR IMPROVING THE BIOAVAILABILITY OF DRUGS WHICH ARE DIFFICULT TO ABSORB AND A PROCEDURE FOR OBTAINING IT
PHARMACEUTICAL PREPARATION FOR PAIN MANAGEMENT
PHARMACEUTICAL PREPARATION FOR PERCUTANEOUS ABSORPTION
PHARMACEUTICAL PREPARATION FOR PREVENTION AND/OR TREATMENT FOR CATARACT
PHARMACEUTICAL PREPARATION FOR PROMOTING EPITHELIAL HEALING AND PREVENTION OF EPITHELIAL DESTRUCTION
PHARMACEUTICAL PREPARATION FOR SUPPLYING FLUORIDE IONS
PHARMACEUTICAL PREPARATION FOR THE MATURATION OF PROTHYMOCYTES
PHARMACEUTICAL PREPARATION FOR THE ORAL ADMINISTRATION OF DIHYDROPYRIDINES
PHARMACEUTICAL PREPARATION FOR THE PREVENTION AND TREATMENT OF BLOOD COAGULATION DISORDERS
PHARMACEUTICAL PREPARATION FOR THE THERAPY OF IMMUNE DEFICIENCY CONDITIONS
PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF GASTROINTESTINAL ULCERS AND HEMORRHOIDS
PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF INFLAMMATORY PROCESSES
PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF TOPICAL WOUNDS AND ULCERS
PHARMACEUTICAL PREPARATION FOR TOPICAL ADMINISTRATION OF ANTIGENS AND/OR VACCINES TO MAMMALS VIA A MUCOSAL MEMBRANE
PHARMACEUTICAL PREPARATION FOR TOPICAL APPLICATION
PHARMACEUTICAL PREPARATION FOR TREATING BLOOD COAGULATION DISORDERS
PHARMACEUTICAL PREPARATION FOR TREATING OR PREVENTING CARDIOVASCULAR OR NEUROLOGICAL DISORDERS BY MODULATING OF THE ACTIVITY OF NITRIC OXIDE SYNTHASE
PHARMACEUTICAL PREPARATION IN FORM OF COATED CAPSULE RELEASABLE AT LOWER PART OF DIGESTIVE TRACT
PHARMACEUTICAL PREPARATION IN THE TREATMENT OF TONSILLITIS
PHARMACEUTICAL PREPARATION OF ANTIHYPERTENSIVE, ANTIANGINAL, ANTIARRHYTHMIC AND ANTIGLAUCOMIC ACTION
PHARMACEUTICAL PREPARATION TO BE ADMINISTERED ORALLY WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE AND METHOD FOR ITS MANUFACTURE
PHARMACEUTICAL PREPARATION WITH CYCLOSPORIN A
PHARMACEUTICAL PREPARATIONS
PHARMACEUTICAL PREPARATIONS AND MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF ENDOTHELIAL DYSFUNCTION
PHARMACEUTICAL PREPARATIONS AND METHODS FOR THEIR ADMINISTRATION
PHARMACEUTICAL PREPARATIONS AND METHODS FOR THEIR REGIONAL ADMINISTRATION
PHARMACEUTICAL PREPARATIONS COMPRISED OF SALTS OF HYALURONIC ACID WITH LOCAL ANAESTHETICS
PHARMACEUTICAL PREPARATIONS CONTAINING A DIBENZOCYCLOOCTANE LIGNAN DERIVATIVE FOR TREATMENT OF NEURODEGENERATIVE DISEASE
PHARMACEUTICAL PREPARATIONS CONTAINING ALENDRONATE SODIUM
PHARMACEUTICAL PREPARATIONS CONTAINING BILOBALIDE FOR THE TREATMENT OF TENSION AND ANXIETY
PHARMACEUTICAL PREPARATIONS CONTAINING ESTRA-1,3,5(10)-TRIENE DERIVATIVES
PHARMACEUTICAL PREPARATIONS CONTAINING HYDROSOLUBLE KETOPROFEN SALTS AND THEIR APPLICATION
PHARMACEUTICAL PREPARATIONS CONTAINING PLATINUM COMPLEXES/PHOSPHONIC ACID LIQUID AND PROCESSES FOR THEIR USE
PHARMACEUTICAL PREPARATIONS CONTAINING POLYUNSATURATED FATTY ACIDS, THEIR ESTERS OR SALTS, TOGETHER WITH ANTIOXIDANT VITAMINS OR PROVITAMINS
PHARMACEUTICAL PREPARATIONS DERIVED FROM EUROPEAN MISTLETOE
PHARMACEUTICAL PREPARATIONS DERIVED FROM KOREAN MISTLETOE
PHARMACEUTICAL PREPARATIONS FOR AMELIORATING EPIGASTRIC FUNCTIONAL DISORDERS
PHARMACEUTICAL PREPARATIONS FOR EXTERNAL USE CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY AND ANALGESIC AGENTS
PHARMACEUTICAL PREPARATIONS FOR INHIBITING TUMOURS ASSOCIATED WITH PROSTATE ADENOCARCINOMA
PHARMACEUTICAL PREPARATIONS FOR INTRANASAL ADMINISTRATION
PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION THAT ARE ADAPTED TO RELEASE THE DRUG AT APPROPRIATE SITES IN THE INTESTINES
PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF BETA-LACTAM ANTIBIOTICS
PHARMACEUTICAL PREPARATIONS FOR THE ORAL ADMINISTRATION OF DIHYDROPYRIDINES IN BEVERAGE FORM
PHARMACEUTICAL PREPARATIONS FOR THE TARGETED TREATMENT OF CROHN'S DISEASE AND ULCERATIVE COLITIS
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFLAMMATORY DISEASES
PHARMACEUTICAL PREPARATIONS FOR TNF INHIBITION
PHARMACEUTICAL PREPARATIONS FOR TREATING SIDE EFFECTS DURING AND/OR AFTER GNRHA THERAPY
PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF ESTROGEN DEFICIENCY IN THE CENTRAL NERVOUS SYSTEM
PHARMACEUTICAL PREPARATIONS HAVING CONTROLLED RELEASE OF ACTIVE COMPOUND AND PROCESSES FOR THEIR PREPARATION
PHARMACEUTICAL PREPARATIONS OF BIOACTIVE SUBSTANCES EXTRACTED FROM NATURAL SOURCES
PHARMACEUTICAL PREPARATIONS OF GLUTATHIONE AND METHODS OF ADMINISTRATION THEREOF
PHARMACEUTICAL PREPARATIONS OF HIGH GASTRIC ACID BINDING CAPACITY, DELAYED EFFECT AND OF INCREASED BIOAVAILABILITY
PHARMACEUTICAL PREPARATIONS WHICH INHIBIT HEPATITIS B VIRUS (HBV) REPLICATION
PHARMACEUTICAL PROCESS USING STARCH
PHARMACEUTICAL PRODUCT
PHARMACEUTICAL PRODUCT COMPRISING A SALICYLATE OF AN ESTERIFIABLE ACE-INHIBITOR
PHARMACEUTICAL PRODUCT COMPRISING SYMPATHOMIMETIC DRUG HAVING THERAPEUTIC PROPERTIES ON THE HUMAN SENSIBILITY AND AUTOCINESIS IN GENERAL
PHARMACEUTICAL PRODUCT CONTAINER WITH TWO SEPARATE SUBSTANCES AND A MIXING DEVICE AND DOSED DISPENSATION
PHARMACEUTICAL PRODUCT CONTAINING LIVE, STABILIZED VIRUS FOR THE THERAPY OF VIRAL AND MALIGNANT DISEASES AND PROCESS FOR PREPARING THE SAME
PHARMACEUTICAL PRODUCT FOR APPLICATION TO UTERUS MUCOSA
PHARMACEUTICAL PRODUCT FOR THE TREATMENT OF SEPSIS
PHARMACEUTICAL PRODUCT HAVING EPIDERMAL REGENERATIVE ACTIVITY BASED ON THE ACTIVE INGREDIENT OF MIMOSA TENUIFLORA AND PROCESS FOR ITS OBTENTION
PHARMACEUTICAL PRODUCT PROTECTION METHOD AND APPARATUS
PHARMACEUTICAL PRODUCTS
PHARMACEUTICAL PRODUCTS COMPRISING A PARASYMPATHOMIMETIC DRUG HAVING THERAPEUTIC PROPERTIES IN THE PATHOLOGY OF HUMAN SENSIBILITY AND THE MOTOR SYSTEM IN GENERAL AND METHOD OF USE
PHARMACEUTICAL PRODUCTS COMPRISING ENDOTHELIAL CELL PRECURSORS
PHARMACEUTICAL PRODUCTS CONTAINING A COMPLEX OF AN AMIDE-TYPE LOCAL ANESTHETIC AND A POLYACRYLATE
PHARMACEUTICAL PRODUCTS CONTAINING THERMALLY-INHIBITED STARCHES
PHARMACEUTICAL PRODUCTS FOR CURING AND PREVENTING ILLNESSES CONNECTED WITH THE MALFUNCTION OF VASCULAR ENDOTHELIAL CELLS
PHARMACEUTICAL PRODUCTS FOR CURING TUMOROUS DISEASES AND PROCESS FOR PREPARING SAME
PHARMACEUTICAL PUMP DISPENSER
PHARMACEUTICAL PUMP DISPENSER FOR FLUID SUSPENSIONS AND FLUID MIXTURES
PHARMACEUTICAL PUMP DISPENSER HAVING HYDRAULICALLY CLOSED OUTLET PORT
PHARMACEUTICAL PYRAZOLE COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES
PHARMACEUTICAL PYRIDINE COMPOUNDS
PHARMACEUTICAL RECORDKEEPING SYSTEM
PHARMACEUTICAL RECORDKEEPING SYSTEM WITH LABELLING FOR MANUFACTURING RAW MATERIALS
PHARMACEUTICAL SOFT CAPSULES CONTAINING LYSINE CLONIXINATE AND A PROCESS FOR THEIR PREPARATION
PHARMACEUTICAL SOLUTION AEROSOL FORMULATIONS CONTAINING FLUOROALKANES AND BUDESONIDE
PHARMACEUTICAL SOLUTION AEROSOL FORMULATIONS CONTAINING FLUOROALKANES, BUDESONIDE AND FORMOTEROL
PHARMACEUTICAL SOLUTION AND METHODS FOR PREPARATION THEREOF
PHARMACEUTICAL SOLUTION CONTAINING FK-506
PHARMACEUTICAL SOLUTIONS AND EMULSIONS CONTAINING TAXOL
PHARMACEUTICAL SOLUTIONS OF LEVOSIMENDAN
PHARMACEUTICAL SOLUTIONS OF MODAFINIL COMPOUNDS
PHARMACEUTICAL SPHEROID FORMULATION
PHARMACEUTICAL STORAGE AND MIXING SYRINGE
PHARMACEUTICAL STORAGE AND MIXING SYRINGE HAVING HIGH PRESSURE ASSISTED DISCHARGE
PHARMACEUTICAL STORAGE AND RETRIEVAL DEVICE
PHARMACEUTICAL SUPERDISINTEGRANT
PHARMACEUTICAL SUPPOSITORY COMPOSITES FOR FEVER AND INFLUENZA AND METHOD OF PRODUCING THE COMPOSITES
PHARMACEUTICAL SUSPENSION COMPRISING NEVIRAPINE HEMIHYDRATE
PHARMACEUTICAL SUSPENSION FORMULATION
PHARMACEUTICAL SUSPENSION FORMULATION COMPRISING AMOXYCILLIN CLAVULANIC ACID AND CELLULOSE
PHARMACEUTICAL SUSPENSION SYSTEMS
PHARMACEUTICAL SUSPENSION TABLET COMPOSITIONS
PHARMACEUTICAL SUSTAINED RELEASE MATRIX
PHARMACEUTICAL SUSTAINED RELEASE MATRIX AND PROCESS
PHARMACEUTICAL SYSTEM IN WHICH PHARMACEUTICAL CARE IS PROVIDED BY A REMOTE PROFESSIONAL SERVING MULTIPLE PHARMACIES
PHARMACEUTICAL TABLET CAPABLE OF LIBERATING ONE OR MORE DRUGS AT DIFFERENT RELEASE RATES
PHARMACEUTICAL TABLET CAPABLE OF RELEASING THE ACTIVE INGREDIENTS CONTAINED THEREIN AT SUBSEQUENT TIMES
PHARMACEUTICAL TABLET CHARACTERIZED BY A SHOWING HIGH VOLUME INCREASE WHEN COMING INTO CONTACT WITH BIOLOGICAL FLUIDS
PHARMACEUTICAL TABLET COMPOSITION
PHARMACEUTICAL TABLET COMPRISING AN NSAID AND MISOPROSTOL
PHARMACEUTICAL TABLET DESIGNED FOR EASIER BREAKING
PHARMACEUTICAL TABLET FORMULATION CONTAINING GABAPENTIN WITH IMPROVED PHYSICAL AND CHEMICAL CHARACTERISTICS AND METHOD OF MAKING THE SAME
PHARMACEUTICAL TABLET OF AMIODARONE SALT
PHARMACEUTICAL TABLET SUITABLE TO DELIVER THE ACTIVE SUBSTANCE IN SUBSEQUENT AND PREDETERMINABLE TIMES
PHARMACEUTICAL TABLET VISION INSPECTION SYSTEM
PHARMACEUTICAL TABLET WITH PVP HAVING ENHANCED DRUG DISSOLUTION RATE
PHARMACEUTICAL TABLET, COMPLETELY COATED, FOR CONTROLLED RELEASE OF ACTIVE PRINCIPLES THAT PRESENT PROBLEMS OF BIO-AVAILABILITY LINKED TO GASTRO-INTESTINAL ABSORPTION
PHARMACEUTICAL TABLETS
PHARMACEUTICAL TABLETS AND CAPSULE GRANULATES OF SCLEROGLUCAN AND ACTIVE SUBSTANCE
PHARMACEUTICAL TABLETS COMPRISING AN NSAID AND A PROSTAGLANDIN
PHARMACEUTICAL TABLETS RELEASING THE ACTIVE SUBSTANCE AFTER A DEFINITE PERIOD OF TIME
PHARMACEUTICAL TETRAHYDROISOQUINOLINES
PHARMACEUTICAL THERAPEUTIC USE OF GLUTATHIONE DERIVATIVE
PHARMACEUTICAL THERAPY FOR CONGESTIVE HEART FAILURE
PHARMACEUTICAL THERMAL INFUSION GRANULES
PHARMACEUTICAL THERMAL INFUSION PROCESS
PHARMACEUTICAL TRAMADOL SALTS |
|
Inventions Browse
Copyright © Philip M. Parker, INSEAD. Terms of Use.